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ABSTRACT 
Sours, Kevin Murphy (Ph.D., Department of Chemistry & Biochemistry)  
Regulation of MAP Kinase Activation Studied by HX-MS 
Thesis directed by Professor Natalie G. Ahn 
Hydrogen exchange mass spectrometry (HX-MS) is an experimental technique 
that can be used to examine solvent accessibility and conformational mobility in 
biological macromolecules. HX-MS is well suited to probe protein solvent accessibility 
and conformational mobility, which can directly relate to cellular behavior and 
regulation. This thesis summarizes studies using HX-MS as the primary experimental 
technique to examine the regulated motions of MAP kinase and their role in protein 
activation.  
MAP kinases are a conserved family of proteins that are important for cellular 
regulation and proliferation that share a conserved secondary and tertiary structure and 
are activated by dual phosphorylation. The first study examines p38α MAPK to see how 
changes in regulated motions upon activation compare between closely related family 
members. Structural analysis such as proteolysis, solvent accessibility, crystal structure 
details and dimerization are investigated and compared to earlier work examining ERK2 
MAPK. The results reveal that even closely related proteins show vastly different 
changes in regulated motions upon activation. This work also touches on experimental 
strategies and methods for optimizing data recovery and resolution which have become 
possible due to the improvement of instrumentation and increased popularity of HX-MS.  
A second study built on past research and investigated changes in the hinge region 
of ERK2, previously identified as a region of interest. These studies examine the role the 
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hinge plays in domain closure, substrate binding, catalysis and the changes that take place 
upon activation. Hinge mutants were created to increase flexibility to help determine the 
role the hinge plays in domain closure which is known to be important in the formation of 
a competent active site. The results suggest that enhanced hinge flexibility upon 
phosphorylation is needed for domain closure. In addition there is preliminary evidence 
that some residues in the hinge are important for ATP binding affinity. Lastly, the 
flexibility in the hinge leads to minimal increase in catalytic activity, indicating more 
than hinge flexibility is crucial for the increase in activity.  
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CHAPTER 1 
 
Introduction: HX-MS as a method for studying regulated motions in proteins. 
 
HX theory, mechanism, and measurements in proteins  
 Studies measuring the exchange rates for amino acid amide hydrogens were 
pioneered by Kaj Linderstrom-Lang in the 1950’s, and by Walter Englander in the 
1970’s. Intrinsic amide hydrogen exchange rates were measured by NMR for each 
residue within oligopeptides under numerous experimental conditions (Bai et al. 1993). 
The exchange rate was measured with varied salinity, pH, temperature and even the 
physical and chemical properties of neighboring residues were considered to ensure the 
rate was determined accurately in many different experimental conditions. These intrinsic 
exchange rates are still the foundation of modern protein hydrogen exchange, but 
subsequent work has yet to define a theory that accurately combines these rates with 
protein secondary or tertiary structure. The lack of an all encompassing theory leads to 
results that are sometimes difficult to interpret. Nonetheless protein hydrogen exchange 
continues to provide valuable insight into protein behavior and is growing in popularity. 
 The chemical exchange reaction can be described as a two part mechanism that 
first involves the abstraction of a proton followed by the addition of a deuteron. This 
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reaction is acid catalyzed at low pH and base catalyzed at high pH (pH >2.5-3). Figure 1 
details this reaction and models how this exchange occurs in proteins. In unfolded 
proteins, or EX1 exchange, the intrinsic exchange rate, kch is much faster than kcl, because 
amide hydrogens are not protected by protein secondary or tertiary structure and as a 
result the measured kobs is approximately equal to kop. Protein folding studies often utilize 
EX1 conditions at high or low pH or in the presence of a denaturant. In contrast, 
exchange can be measured in native folded proteins, by what is known as EX2 exchange. 
Measurements under EX2 conditions maintain the functionality and biological 
characteristics of the protein. For proteins in their native conformation and at neutral pH, 
the reaction is often described by a two state mechanism where exchange occurs through 
protein fluctuations that transiently expose protons to solvent, followed by exchange with 
deuterium. In other words, as the protein samples an ensemble of conformations, 
backbone amide hydrogens become exposed and exchange with deuterons from D2O 
solvent. In EX2 exchange the observed rate (kobs) is a function of the open (kop) / close 
(kcl) equilibrium times the intrinsic exchange rate (kch). There is a general consensus that 
secondary and tertiary structural features, such as hydrogen bonds, packing interactions, 
and distance to surface (ex: probability of solvent exposure) of native folded proteins 
affect the exchange rate, but this is poorly understood and impossible to predict. Even 
without an all encompassing theory both exchange regimes have been used to study 
protein structure and function. 
 At its most basic application, hydrogen exchange has the ability to report on 
protein conformation and conformational mobility, but it also has the ability to report on 
protein dynamics under certain experimental conditions. By measuring kobs under both 
2
AB
C
Figure 1: Mechanism of HX in proteins. A. The two part exchange 
reaction where the top reaction details the base catalyzed proton 
abstraction and the bottom reaction details the acid catalyzed  deu-
teron addition. B. This scheme shows the exchange as it occurs in 
proteins with the top reaction occuring in native folded protein with 
small fluctuations and the bottom reaction occuring in unfolded 
protein. C. Kinetic parameters for exchange in proteins. The EX1 
parameters apply for unfolded protein, the bottom scheme of B, while 
the EX2 parameters apply for native folded protein, the top scheme in 
B. Figure adapted from Hoofnagle et al. 2003.
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EX1 and EX2 regimes and applying Englander’s intrinsic rate measurements, the values 
for kop and kcl as well as the Gibbs free energy (ΔG) can be determined. The Robertson 
lab utilized hydrogen exchange coupled to mass spectrometry and NMR under EX1 and 
EX2 conditions to determine the kop and kcl rate constants and ΔG for specific backbone 
amides in turkey ovomucoid third domain (OMTKY3) and ubiquitin (Arrington et al. 
1999, Arrington & Robertson, 2000a, Arrington & Robertson, 2000b, Sivaraman et al. 
2001, Ferraro et al. 2004). While it was not surprising that kcl values were significantly 
faster than kop for native proteins, it was interesting that the rate constants spanned four 
orders of magnitude in OMTKY3 (30 – 40 x 104 s-1) and five orders of magnitude in 
ubiquitin (0.8x10-3 – 57 s-1). It is noteworthy that all of the rate measurements in 
ubiquitin were significantly slower than those in OMTKY3, suggesting differences in 
conformational mobility and rigidity at least under these experimental conditions. Despite 
the differences in rate, the ΔG values for specific backbone amides for each protein 
remained similar, between 1 – 8 kcal/mol, suggesting little difference in the energy 
requirement for backbone mobility. These results eloquently illustrate how amide HX can 
be applied to improve our understanding of backbone conformational mobility and 
protein behavior. While all of the experiments discussed here were performed under EX2 
conditions so the specific kop and kcl rates could not be determined, much was learned 
about the role conformational mobility plays in MAP kinase activation. 
 
Recent evolution of hydrogen exchange 
Hydrogen-deuterium exchange (HX) methods have provided useful approaches 
for exploring conformational and dynamic properties of biomolecules.  Although often 
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performed by nuclear magnetic resonance (NMR), HX coupled with mass spectrometry 
has increased in popularity over the last fifteen years (Hoofnagle et al., 2003; Englander, 
2006).  Advances in the resolution and speed of mass spectrometry instrumentation allow 
experiments to be performed readily on macromolecules.  Early publications provided the 
basic strategy for HX-MS of proteins, which are still prevalent among current studies of 
protein folding, macromolecular interactions, ligand binding, enzyme activation, and 
conformational mobility (Zhang & Smith, 1993; Johnson & Walsh, 1994).  
Measurements of HX by NMR has advantages but also has drawbacks that can be 
difficult to overcome.  An advantage of NMR is its ability to examine individual residues 
and directly measure HX rates at specific backbone amides in a folded protein.  HX 
experiments by NMR have been applied to well characterized proteins such as 
cytochrome c and ubiquitin to correlate HX rates and corresponding changes in protein 
behavior.  For example, HX has been used to monitor protein-protein interactions 
between cytochrome c and monoclonal antibody, protein folding including rates of 
folding and properties of intermediates, and the relationship between protection factors 
and secondary and tertiary structural motifs (Mayne et al., 1992; Paterson et al., 1990; 
Roder et al., 1988; Englander & Mayne, 1992; Marmorino et al., 1993; Briggs & Roder, 
1992; Milne et al., 1998). 
HX measurements by NMR also have drawbacks.  First, NMR peaks need to be 
assigned to residues which can be incomplete and time consuming.  This becomes 
increasingly difficult as the protein size increases and peaks in spectra become more 
complicated and less well resolved.  In addition, NMR often requires protein 
concentrations in the millimolar range for good signal to noise which can be problematic 
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for proteins that are insoluble or tend to aggregate at high concentrations.  HX 
measurements by NMR also require dissolution of lyophilized proteins or dilution of 
concentrated proteins into D2O, followed by insertion of the sample into the instrument.  
This introduces a dead time of several minutes, which limits the ability to measure fast-
exchanging amides (Smith et al., 1997). 
Many of these limitations can be overcome by HX-MS.  An examination of the 
benefits of HX-MS illustrates why the technique has grown so rapidly in popularity in 
recent years and why researchers are constantly developing new applications.  This is in 
part because of improved technologies for mass spectrometry over the last two decades, 
and the growth in the field of proteomics, which continue to drive the technology 
forward.  Mass spectrometers have highly sensitive, down to sub-picomole amounts, 
allowing an entire HX-MS experiment to be performed with protein levels in the 
microgram to nanogram range.  This allows working with proteins that are hard to 
express or insoluble, and at concentrations closer to cellular levels.  HX-MS reactions can 
also be quenched after seconds (or milliseconds with the help of quench-flow 
instrumentation) so that fast-exchange rates can be measured (Dharmasiri & Smith 1996).  
HX-MS also has the ability to analyze large proteins or protein complexes, with the 
current record held by HX studies on a 250 kDa protein complex (Wales et al., 2008).  
Two significant drawbacks of HX-MS are its limited resolution in determining the 
site(s) of HX and the lengthy time needed for data analysis and interpretation.  HX-MS 
resolution is currently limited by the length of peptides generated by proteolysis, which 
are usually 5-20 residues long.  However, this limitation is starting to be solved by new 
advances in instrumentation.  For example, each generation of mass spectrometers allows 
6
faster scanning, and combined with higher resolution in HPLC or UPLC, allows high 
sequence coverage and increased number of peptides that overlap in sequence.  
Combined with improvements in proteolysis, which utilize alternative proteases, 
overlapping peptides can specify resolution down to 2 – 4 residues (Cravello et al., 2003).  
In addition, advances in nebulization and fragmentation strategies have allowed 
fragmentation of deuterated peptides.  Previous attempts using collision induced 
dissociation led to deuteron scrambling, but new methods using electron transfer 
dissociation with controlled gas phase temperatures enable fragmentation without 
scrambling (Ferguson & Konermann, 2008; Rand et al., 2009; Zehl et al., 2008).  The 
reliability of sequencing can be validated by the degree of N-terminal deammoniation and 
lack of integral deuteration at specific positions (Rand et al., 2010).  With these advances 
HX-MS is rapidly advancing towards single amide resolution.  However, since HX-MS 
provides no structural information, it is still beneficial to have atomic resolution X-ray or 
NMR structures to aid in interpretation of results.  
A second limitation of HX-MS is that mass spectrometers produce large amounts 
of data, and with high sequence coverage, many peptides to analyze.  Data analysis is 
usually the most time consuming part of the experiment, and often data analysis takes 
anywhere from a few days to several months, depending on the size of the experiment.  
However, new software allows semi-automated to fully-automated data analysis, 
enabling reductions in analysis time (Sours & Ahn, 2010).  Custom HX-MS liquid 
chromatography instrumentation is now being commercially produced with software for 
rapid data analysis (Wales et al., 2008).  All of this has led to fewer obstacles in the HX-
MS experiment and increased popularity for protein studies. 
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A common question regarding HX studies is its interpretation with respect to 
protein backbone mobility and what these changes actually tell us about protein motions.  
The OMTKY3 study by the Robertson lab discussed above used HX-NMR and HX-MS 
in a complementary manner to measure backbone folding and unfolding behavior in 
solution.  This study revealed that local unfolding was predominant and showed rate 
measurements spanning four orders of magnitude.  Using HX-MS and modeling to 
complement the HX-NMR data, these investigators showed that multiple unfolding 
reactions occur in the native protein and these may or may not correlate with exchange at 
backbone amides.  This led to the idea that the unfolding reactions can proceed through 
correlated or uncorrelated backbone motions, depending on the local region of the protein 
in question, leading to an ensemble of states the protein can adopt before global 
unfolding occurs (Arrington et al., 1999; Arrington & Robertson, 2000).  These studies 
together produced a more complete picture of OMTKY3 folding, illuminating how useful 
HX can be.  
 
HX-MS applied to protein kinases 
HX-MS has proven to be a powerful method for obtaining new insight into 
protein kinase regulation, specifically involving interactions with other proteins, changes 
upon substrate binding, and identification of intramolecular allosteric networks.  An 
excellent example is recent work from John Engen’s lab on the oncogenic protein kinase 
Bcr-Abl, whose dysregulated activity is responsible for the onset of chronic myelogenous 
leukemia (CML).  Engen and coworkers utilized many approaches to define the 
biochemical properties of Bcr-Abl, but HX-MS has been their primary tool for analyzing 
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kinase conformational mobility.  The Bcr-Abl fusion protein consists of an NCap domain, 
SH2 and SH3 domains, and a linker to the kinase domain (Chen et al., 2007).  HX-MS 
has revealed multiple allosteric networks between the domains of Bcr-Abl and 
throughout the kinase domain (Iacob et al., 2008; Chen et al., 2008a; Chen et al., 2008b; 
Zhang et al., 2010).  They have documented existing interconnecting networks between 
the activation lip phosphorylation site, phosphorylation sites in the SH3 and linker 
regions (Y89 & Y245), the myristate-binding pocket, and the “gatekeeper” residue 
(T315).  Phosphorylation at Y89 has been shown to disrupt the interactions between the 
SH2, SH3, and linker domain, leading to decreased affinity for substrate peptide.  
Disruption of the SH3 domain with the linker is predicted to lead to dynamic changes and 
kinase activation (Chen et al., 2008a; Chen et al., 2008b).  The myristoylated Bcr-Abl has 
lower activity which has been shown to be dependent on dynamic and conformational 
changes throughout the entire protein (Chen et al., 2008a; Chen et al., 2008b; Iacob et al., 
2008).  When myristic acid is bound, the NCap stabilizes the SH3 domain, but only in the 
presence of the SH2 domain.  The addition of the myristic acid also leads to a 
conformation where the SH2 domain is on top of the small lobe of the kinase, leading to 
down-regulated kinase activity.  This conformation has been observed by X-ray 
crystallography while the allosteric networks can be observed by HX-MS (Chen et al., 
2008a; Chen et al., 2008b; Iacob et al., 2008).  Lastly, it has recently been shown that the 
myristate binding pocket communicates with the T315 “gatekeeper” residue and substrate 
binding pocket.  While this network is not completely understood it was found that 
binding of kinase inhibitor binding to both sites might provide a promising method for 
inhibition of Bcr-Abl activity and treatment of CML patients (Zhang et al., 2010).  The 
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interconnecting allosteric networks of Bcr-Abl that have been illuminated through HX-
MS analysis prove the power of this technique for investigating biochemical properties 
and kinase regulation.  
Another use for HX-MS is its ability to map binding sites of protein-protein 
interactions, substrate binding, or small molecule ligands.  Hamuro et al. (2002) 
investigated the binding of AMP-PNP and ADP to Csk, the tyrosine kinase, by HX-MS.  
Both ligands protected regions surrounding the active site; however, the smaller ADP 
molecule protected the Gly-rich loop in the N-terminal lobe to a greater extent than 
AMP-PNP whereas AMP-PNP led to allosteric changes in regions of the protein far from 
the binding site.  Although the basis of these differences are not entirely understood, the 
authors speculate that some are due to changes in protein mobility, while others are due 
to larger conformational rearrangements.  It is interesting to see differences in protein 
behavior introduced by the γ-phosphate as detected by HX-MS, an insight not obvious 
from X-ray crystallography.  
HX-MS has also been used to understand binding interactions between ERK2 and 
substrate as well as with MAP kinase phosphatases (MKP) (Lee et al., 2004; Zhou et al., 
2006).  One study used HX-MS to identify binding sites for docking motifs, sequences 
within substrates and scaffolds, which confer high affinity binding to MAP kinases (Lee 
et al., 2004).  Binding of a DEJL docking motif (consensus sequence Arg/Lys-X2-4-Φ-X-
Φ) interacted with a hydrophobic groove previously identified in X-ray co-crystal 
structures, while a DEF docking motif (consensus Phe-X-Phe) interacted with a novel 
binding pocket formed upon rearrangement of the activation lip following 
phosphorylation.  In studies of the binding interface between ERK2 and MKP3 (Zhou et 
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al., 2006), HX-MS was used to map regions within kinase and phosphatase that were 
protected from exchange in the heterodimeric complex.  Site-directed mutagenesis 
confirmed that binding of MKP3 involved the DEJL and DEF docking motif binding 
sites and the activation lip of ERK2, while binding of ERK2 involved corresponding 
docking motif sequences in MKP3, revealing that two distinct domains in the MKP3 
interact with distally spaced regions in ERK2.  These studies highlighted the importance 
of structural changes in ERK2 following activation and how they direct binding of 
substrates and phosphatase regulators.  
These studies illustrate how HX-MS can be effective for understanding the 
regulation of protein mobility and its importance for kinase activation, as well as protein 
interactions involved in kinase enzymatic function and regulation.  Additional studies 
showed that activation of p38 MAPK and MKK1 also caused changes in HX that were 
consistent with regulated conformational mobility (Resing et al., 1999; Sours et al., 
2008).  Such changes occur within distinctive regions of each enzyme, suggesting that 
regulated motions vary significantly across related MAP kinases.   
In these studies we expand on previous work examining the activation of MAP 
kinase by using HX-MS to address two outstanding questions regarding the regulation of 
MAP kinase activation.  One, how do closely related members of the MAP kinase family 
compare in their control of regulated mobility upon activation as detected by HX-MS?  
Here we compare proteins in the MAP kinase family, namely p38α and ERK2.  While 
solvent accessibility throughout the family remains similar, interestingly, the regulation 
of activation appears to have evolved differently even between close family members.  
Two, is enhanced backbone flexibility in the ERK2 hinge after activation needed for 
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domain closure?  Hinge mutants were studied to determine how hinge flexibility controls 
domain closure, which is known to be important for catalysis.  The results suggest that 
enhanced backbone flexibility in the hinge region upon phosphorylation is needed to 
promote domain closure and formation of a competent catalytic site.  In addition, the 
results suggest that some residues in the hinge are important for ATP binding affinity.  
While interactions between the hinge and the adenine ring are well documented, how 
these interactions contribute to binding affinity has not been examined.  Lastly, the 
flexibility in the hinge leads to minimal increase in catalytic activity, indicating more 
than hinge flexibility is crucial for the increase in activity.  Further investigations are 
needed to understand how changes in protein mobility control kinase activation and how 
backbone flexibility is controlled by phosphorylation.   
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CHAPTER II 
 
Analysis of regulated motions in the MAP kinase p38α measured by HX-MS. 
 
INTRODUCTION 
MAP kinase (MAPK) family members, including various forms of ERK, JNK and p38 
MAPK, control diverse aspects of cellular regulation.  p38 MAPKs and JNKs regulate responses 
to stress and inflammation while ERKs regulate events required for cell proliferation, motility 
and differentiation.  Many family members are under exploration as drug targets, and inhibitors 
of p38 show therapeutic effects towards diseases of inflammation (Lee et al., 2000).  MAPKs are 
closely related by sequence, with p38α MAPK sharing 48% sequence identity with ERK2 and 
60% identity with p38β and p38γ MAPK forms. 
Mechanisms for activating MAP kinases are conserved.  Like other protein kinases, they 
display a conserved bilobal kinase structure, consisting of an active site located between an N-
terminal ATP binding domain and a C-terminal substrate binding domain (Johnson et al., 2001). 
Each MAP kinase is activated by dual phosphorylation at a pThr-Xxx-pTyr sequence motif 
located within the activation lip.  This leads to conformational changes around the active site, 
which are best understood for ERK2, the only MAP kinase for which X-ray structures of both 
inactive and active forms have been determined (Zhang et al., 1994; Canagarajah et al., 1997). 
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Three major changes occur as a result of dual phosphorylation. First, ion-pair interactions 
between the phosphorylated residues and basic side chain amino acids cause a dramatic 
reorganization of the activation lip, into a conformation which enables substrate binding and 
recognition of a Ser/Thr-Pro sequence motif for phosphorylation. Second, ion pair interactions 
lead to connectivity between the lip and N-terminal helix αC as well as repositioning of active 
site residues for catalysis. Third, a docking motif binding site forms upon reorganization of the 
activation lip, enabling high affinity substrate binding (Lee et al., 2004). Thus, dual 
phosphorylation and activation lip remodeling lead to conformational changes which facilitate 
substrate binding and formation of a competent catalytic site.  
In addition to conformational changes, protein kinase activation causes changes in 
internal protein motions as determined by hydrogen exchange-coupled mass spectrometry (HX-
MS) (Resing & Ahn, 1998; Hoofnagle et al., 2001).  By examining hydrogen exchange with D2O 
on peptides formed by proteolysis, localized effects within a molecule can be detected 
(Hoofnagle et al., 2003, Hoofnagle et al., 2004b; Busenlehner & Armstrong, 2005).  Several 
studies have now shown that hydrogen exchange measurements on kinases detect localized 
changes in protein fluctuations which are low energy and not always observable by X-ray 
crystallography (Hoofnagle et al., 2001; Hamuro et al., 2003; Wong et al., 2004; Alverdi et al., 
2007).  These can include motional changes, in which a protein adopts conformers which differ 
by free energies on the order of 1 kcal/mol.  Regulation of protein fluctuations and flexibility 
could lead to changes in protein function, even when structural changes are not apparent.   
HX-MS measurements reveal that in ERK2, kinase activation leads to changes in 
hydrogen-deuterium exchange at backbone amides within the hinge region separating N- and C-
terminal domains (Hoofnagle et al., 2001).  Because X-ray structures show that atoms within the 
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hinge region are superimposable between active and inactive forms, the corresponding changes 
in HX have been ascribed to regulated conformational mobility. In agreement, site-directed spin 
labeling EPR measurements show activation-induced changes in correlation times of side chains 
at hinge residues (Hoofnagle et al., 2004).  Furthermore, evidence from HX-MS suggests that 
regulated protein motions are important for activation.  In the active form of ERK2, the 
nonhydrolysable ATP analog, AMP-PNP, sterically protects amides from hydrogen-deuterium 
exchange in both the N and C-terminal domains of the ATP binding pocket (Lee et al., 2005).  In 
contrast, only the N-terminal domain is protected from exchange by AMP-PNP in the inactive 
form of ERK2.  This indicates that in solution, the N- and C-terminal lobes in active ERK2 adopt 
a closed conformation around nucleotide, whereas inactive ERK2 is somehow constrained from 
interdomain closure and instead adopts an open conformation.  Together, the evidence suggests 
that increased backbone flexibility at the hinge following ERK2 phosphorylation enables 
induced fit interdomain closure, a necessary event for catalytic function.  
X-ray structures of p38α MAPK and JNK1 in their inactive forms show large diversity in 
activation lip conformation (Wang et al., 1997; Wilson et al., 1996; Xie et al., 1998; ter Haar et 
al., 2007; White et al., 2007). Although structures of corresponding active forms are not 
available, an X-ray structure of diphosphorylated active p38γ MAPK reveals that the activation 
lip adopts a conformation similar to that of diphosphorylated active ERK2 and the cAMP 
dependent kinase catalytic subunit (Bellon et al., 1999).  Thus, the diverse activation lip 
conformations in various inactive forms of MAPKs converge towards a uniform active state 
conformation that confers catalytic rate enhancement.  This is expected, because only a limited 
range of structures should produce catalytic function (Nolen et al., 2004).  In addition, active 
p38γ MAPK shows greater closure between N- and C- terminal domains due to a rigid body 
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rotation of >15 º compared to inactive p38α MAPK, where the domains are held in an open 
conformation (Bellon et al., 1999).  In contrast, structures of ERK2 show a smaller difference in 
domain rotation (5 º) between active and inactive forms (Canagarajah et al., 1997).    
To date there is no information available as to whether phosphorylation-dependent 
changes in conformational mobility are also similar between different MAPKs.  On one hand, 
MAPK family members share similarities in primary sequences, activation mechanisms, and 
structural motifs.  On the other hand, small differences in sequence may yield large differences 
in control of regional flexibility.  Conceivably, the role that protein internal motions play in 
activation may differ significantly between these closely related enzymes.  
Here, we investigate the effect of kinase activation on conformational mobility of p38α.  
By monitoring peptide sequences over the entire protein we present a global picture of amide 
hydrogen exchange behavior, and how this differs between active and inactive forms of the 
kinase.  Overall, the patterns of in-exchange are similar between p38α and ERK2, reflecting their 
similarities in sequence and structure.  Upon p38α activation, regional changes in hydrogen 
exchange are observed, some of which can be ascribed to changes in structure and others to 
conformational mobility.  This suggests that kinase activation regulates mobility within localized 
regions.  Importantly, the patterns of regulated mobility differ significantly between p38α and 
ERK2.  Thus, closely related MAP kinase family members show divergent behavior with respect 
to effects of phosphorylation and activation on protein motions. 
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MATERIALS AND METHODS 
Proteins. 
Doubly phosphorylated active kinase (2P-p38α) was produced in BL21(DE3)-pLysS 
using the plasmid pET(His)-MKK6DD/p38α, which expresses wild-type mouse His6-p38α and 
constitutively active MKK6, as previously described (Wilsbacher & Cobb 2001).  
Unphosphorylated, inactive kinase (0P-p38α) was produced in pET(His)-MKK6DD/p38α 
modified by deleting the MKK6 open reading frame.  Monophosphorylated, inactive kinase (1P-
p38α) was produced in pET(His)-MKK6DD/p38α modified by inserting a stop codon at residue 
Tyr64 of MKK6.  Each kinase was purified using Ni-NTA agarose (Qiagen) chromatography 
and MonoQ FPLC (14), dialyzed overnight into 50 mM KPO4 (pH 7.4), 100 mM KCl, and 5 mM 
dithiothreitol (DTT), and stored in aliquots at -80°C.  Mass spectrometry confirmed 
phosphorylation stoichiometry at the activation lip, where 0P-p38α was >99% 
unphosphorylated, 2P-p38α was >99% diphosphorylated at Thr180 and Tyr182, and 1P-p38α 
was 85% monophosphorylated at Tyr182 and 5.5% at Thr180 (data not shown). 
 
Hydrogen-exchange mass spectrometry (HX-MS) measurements   
Data collection and analysis of weighted average mass, in-exchange, and back exchange 
was performed as described (Resing et al., 1999; Hoofnagle et al., 2004; Lee et al., 2006).  Data 
were collected on a QStar Pulsar QqTOF MS interfaced with an Agilent Cap1100 HPLC (500 
μm i.d. x 10 cm column, packed with POROS R1 20 resin).  Proteins (4 μg) were incubated in 
90% D2O at 10°C allowing the in-exchange reaction to take place from 8 s to 4 h. Reactions 
were quenched with 90 μL 25 mM succinic acid, 25 mM citric acid (pH 2.4), and cooled rapidly 
to 0°C.  Proteins were digested by adding 10 μL pepsin (4 μg), and analyzed by LC-MS.  Time-
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zero measurements were performed by quenching the reaction before adding D2O.  Samples 
were randomized to control for systematic variations, and replicate runs were performed at 0 s, 
60 s, and 1800 s.  Across all time points, the average standard deviation of weighted average 
mass was 0.05 Da, with maximum standard deviation 0.13 Da. Deuteration time courses were 
corrected for artifactual in-exchange and back-exchange, then fit to a sum of exponentials.   
Weighted average mass calculations were carried out using HX-Analyzer, an interactive 
tool for increasing accuracy and speed of analysis of HX-MS data, developed in-house and 
implemented in Visual Basic using ABI Analyzer QS, MS Office XP, and MS XP software 
library modules.  HX-Analyzer inputs a list of LC-MS/MS files (.wiff) and a spreadsheet 
summarizing information about peptide ion mass and approximate elution time, presents isotopic 
peaks for examination across several datasets for manual inspection, and then outputs isotopic 
masses and weighted average mass for each peptide ion.  HX time courses were fit by nonlinear 
least squares (NLSQ) to the equation Y = N – Ae -k1t – Be –k2t – Ce –k3t, where Y is the number of 
deuterons exchanged at time t, A, B, and C are the number of backbone amides exchanging at 
rates k1, k2, and k3, N is the maximal deuteration over the experimental time period (N = A + B + 
C).  Subtracting N from the total number of exchangeable backbone amides yields NE, the 
number of amides that are non-exchanging over the experimental time period (Hoofnagle et al., 
2004; Lee et al., 2006).  NLSQ curve fitting was performed and results plotted using DataFit 7.1 
(Oakdale Engineering). 
For LC-MS/MS, proteins incubated in water were treated and proteolyzed as above.  
Samples (4 μg) were analyzed on the Pulsar mass spectrometer with m/z window = 400-1600 
Da, duty cycle 15.5 s, and 3 MS/MS per cycle.  Samples (60 ng) were analyzed on the LTQ-
Orbitrap mass spectrometer interfaced with an Eksigent 2DLC HPLC (75 μm i.d. x 150 mm 
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column, Zorbax C18 resin), with  m/z window = 300-2000 Da, duty cycle 4-6 s (~10-14 
cycles/min), and 5 MS/MS per cycle.  MS/MS were converted to .mgf files and searched against 
the p38α sequence using the Mascot search program (v.1.9), with no enzyme specified.  Mass 
tolerances used for Pulsar datasets were 2.5 Da for parent ions and 1.2 Da for fragment ions.  
Mass tolerances for LTQ-Orbitrap datasets were 1.2 Da for parent ions and 0.8 Da for fragment 
ions.  The Manual Analysis Emulator was used to generate theoretical spectra for the top two 
sequence assignments made by Mascot, and Similarity scores evaluating overlap between 
theoretical and observed spectra were calculated as described (Sun et al., 2006).  High 
confidence thresholds used were Mowse = 30 and Similarity = 0.5, which yielded false discovery 
rate (FDR) = 0.3%.   
 
Analytical ultracentrifugation equilibrium experiments 
Sedimentation equilibrium analyses were performed on a Beckman Proteomelab XLI 
analytical ultracentrifuge with absorbance optics at 280 nm for the detection of aromatic 
residues.  Samples were loaded into 12 mm Epon cells at concentrations ranging from 0.32 
to 0.44 mg/ml. The samples were then centrifuged at 20 °C at 20,000, 24,000, and 28,000 x g for 
24 h to achieve equilibrium, and successive radial absorbance scans were recorded.  Protein 
molecular weights and oligomerization behavior were determined by fitting the sedimentation 
equilibrium data from different initial loading concentrations and rotor speeds to various 
monomer-oligomer equilibrium schemes using WIN NonLIN (v.1.035, University of 
Connecticut) fitted to theoretical partial specific volumes based on compositions (Johnson et al., 
1981). The partial specific volume of the sample and density of the buffer were calculated using 
SednTerp (v.1.06, University of New Hampshire) using the weighted average of the amino acid 
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content. To obtain observed molecular weight, dissociation constants, oligomerization states, 
absorbance results were converted to linear plots of ln(AU) versus r2 (radius) to the theoretical 
monomer and dimer (single-species models) using the equation: 
  Cr = Co exp [M ((1-vbar)ρ) ω2 (r2+ro2) / 2 RT ]   
where Cr is the concentration at radius r(A), Co is the concentration at the meniscus, M is the 
monomer molecular weight, vbar is the partial specific volume calculated by SednTerp, ρ is the 
buffer density, and ω is the angular velocity. 
 
RESULTS 
Achieving high coverage of exchangeable amide hydrogens 
HX measurements were made by incubating protein in D2O for varying periods of in-
exchange.  After quenching the in-exchange reaction, proteins were proteolyzed, and extent of 
deuteration was quantified by LC-MS mass measurements of peptides in the digest.  High 
coverage of exchangeable amides over the protein sequence is needed in order to obtain a global 
view of amide hydrogen exchange behavior.  In addition, because resolution is limited in 
peptides with large numbers of residues, greater recovery of peptides with overlapping sequences 
allows exchange behavior to be localized within narrower protein regions.  Thus, techniques that 
maximize identification of peptides from proteolytic digests are needed to optimize HX 
measurements.   
In an effort to maximize peptide identifications, we examined the influence of sampling, 
instrument, and peptide search algorithm on peptides observed in LC-MS/MS datasets of p38α.  
Peptides present within protein digests are often missed because they fail to be identified with 
high confidence.  Sampling statistics often limit the number of peptides that are sequenced in any 
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MS/MS run, when digests are complex.  Low instrument sensitivity may limit the ability to 
sequence low abundance ions.  Finally, automated search programs may yield scores that are too 
low to confidently match peptide sequences to MS/MS spectra.  
Three experiments were carried out to examine how each of these factors affects 
coverage and resolution (Figure 1A).  p38α incubated in water was proteolyzed and peptides 
were sequenced by LC-MS/MS, identifying peptides using the Mascot search program.  Two 
instrument platforms were used for LC-MS/MS.  The QStar Pulsar is a quadrupole time-of-flight 
(TOF) mass spectrometer which is used to perform HX mass measurements by LC-MS, as well 
as LC-MS/MS sequencing.  The LTQ-Orbitrap is an ion trap mass spectrometer which provides 
fast MS/MS scan rates, high sensitivity, and high mass accuracy.  Peptides were then matched to 
those routinely observed in HX-MS datasets of p38α incubated in D2O to allow in-exchange.  In 
each experiment, effects on sequence coverage and number of exchangeable amides were 
quantified.  
The first experiment tested the effect of sampling on sequence coverage.  Peptide 
identifications may be enhanced by repeating LC-MS/MS runs on the same digest, which 
increases sampling depth and the probability that an ion will be selected for MS/MS. LC-MS/MS 
performed on the Pulsar identified 39 peptides in a single run, yielding 77% sequence coverage.  
Combining results from 3 or 9 runs respectively yielded 77 peptides (88% sequence coverage), 
or 98 peptides (99% coverage) (Table 1, Table 2).  Of these, respectively 30, 45, and 67 peptides 
could be routinely identified in HX-MS datasets under conditions of p38α deuteration 
identifying peptides using the Mascot search program.  Therefore, increasing the depth of 
sampling by performing 3 or 9 LC-MS/MS runs respectively improved peptide recovery by 1.5-
fold or 2-fold over a single run, and increased the percentage of peptide identifications may also 
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A Bp38α MAPK
Pepsin digestion
Pulsar LTQ Orbitrap
Mascot Mascot Mascot
MAE
p38α peptide database
  LTQ-
Orbitrap
 77(34)
79(58)Pulsar19(9)
Figure 1.  Methods for LC-MS/MS data collection and analysis.  (A) Experiments used to identify 
peptides created by pepsin digestion.  Purified p38α was proteolyzed and peptides sequenced by 
LC-MS/MS on Pulsar QqTOF and LTQ-Orbitrap mass spectrometers.  Data were analyzed using the 
Mascot search program and post-processed using Manual Analysis Emulator (MAE) in-house 
software, then compiled into a database of observed peptides (Table 1).  (B) Peptides identified from 9 
replicate LC-MS/MS runs collected on the Pulsar mass spectrometer and 3 replicate runs collected on 
LTQ-Orbitrap mass spectrometer.  Numbers indicate total unique peptides, and parentheses indicate 
unique peptides matched to ions observable in HX-MS datasets. 
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be enhanced by fast scanning mass spectrometers which increase the number of MS/MS attempts 
in a single LC-MS/MS run.  In a second experiment, we addressed the effects of instrument 
sensitivity and scan rate, by analyzing p38α digests on an LTQ-Orbitrap mass spectrometer, 
which is sensitive to low femtomoles and collects MS/MS ~4-5 times faster than the Pulsar.  A 
single LC-MS/MS run identified 95 peptides, of which 61 were observable in HX-MS datasets, 
covering 72% of exchangeable amides (Table 1, Table 2).  Three LC-MS/MS runs yielded 110 
peptides, of which 68 were observable in HX-MS datasets, representing 81% amide coverage.  
Thus, replicate runs on the LTQ-Orbitrap yielded greater numbers of peptides, consistent with 
the higher sensitivity and faster scan rate of this instrument.  However, most of the additional 
peptides yielded overlapping sequence information, and surprisingly, the amide coverage from 
peptides sequenced by the LTQ-Orbitrap was not significantly higher than that of the Pulsar.  
This suggested that another factor limits peptide identification. 
A third experiment asked whether peptide identifications could be impacted using 
improved methods for matching MS/MS spectra to peptide sequences.  Conventional search 
programs match m/z values between fragment ions observed in MS/MS spectra and those 
calculated from peptide sequences.  This is the case for Mascot, which calculates a MOWSE 
score using a probabilistic model to evaluate the likelihood of observing fragments from a given 
sequence (Perkins et al., 1999).  Recent studies have shown that correct matches which fall 
below high confidence MOWSE thresholds can be successfully captured using Similarity scores 
which evaluate relative intensities of fragment ions as well as m/z (Zhang, 2004; Zhang, 2005; 
Sun et al., 2006).  We incorporated this principle into in-house software named the Manual 
Analysis Emulator (MAE) (Sun et al., 2006), which uses the MassAnalyzer algorithm of Zhang 
(Zhang 2004; Zhang 2005) to simulate relative intensities of fragment ions in theoretical MS/MS 
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spectra and then rescores assignments made by Mascot using Similarity scoring. This has the 
effect of capturing peptides which are correct sequence assignments, but are rejected because 
MOWSE scores are low.  
The datasets from 3 LC-MS/MS runs on the LTQ-Orbitrap (Experiment 2) were rescored 
using MAE.  By accepting assignments with either MOWSE or Similarity scores above high 
confidence thresholds, 156 peptides were identified, covering 99% of the p38α sequence (Table 
1, Table 2).  Of these, 92 were observable in HX-MS datasets, representing 95% of exchangeable 
amides.  Thus, improved scoring methods yielded higher data capture, so that the 3 LC-MS/MS 
runs on the LTQ-Orbitrap provided equivalent amide coverage and 60% more peptides with 
overlapping sequences, compared to 9 LC-MS/MS runs on the Pulsar.  As expected, the LTQ-
Orbitrap experiments identified more ions with low intensity compared to the Pulsar experiments 
(data not shown), although very weak ions were often filtered out because they were not 
observed in HX-MS datasets.  Importantly, our results suggest that MS/MS fragmentation differs 
between the LTQ and Pulsar instruments in a way which differentially affects the resulting 
MOWSE scores.  The fact that sequence coverage was similar between the LTQ-Orbitrap and 
Pulsar in Experiments 1 and 2 implies that certain peptide sequences are less readily identified 
from MS/MS collected on the ion trap instrument, and that rescoring algorithms like MAE are 
needed to capture these sequences.  
Peptide yields are summarized in Figure 1B and Figure 2, showing unique peptide 
sequences observed with each instrument, ignoring redundancies due to multiple ion forms with 
different charge states.  A total of 175 peptides and 101 HX-MS-observable peptides were 
identified between the two instruments (Table 1).  Of these, 45% of total peptides and 57% of 
HX-MS-observable peptides were observed by both instruments (Figure 1B).  Our combined 
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Figure 2.  Peptides recovered by LC-MS/MS.  Green indicates peptides observed
in both Pulsar and LTQ-Orbitrap datasets.  Cyan indicates peptides observed only in 
LTQ-Orbitrap datasets.  Yellow indicates peptides observed only in Pulsar datasets. 
Sequence coverage map of p38α, indicating residue numbering and secondary 
structures as reported (Wang et al., 1997; Wilson et al., 1996).  
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datasets from 12 LC-MS/MS experiments yielded 98% coverage of exchangeable amides (Table 
1), with greater resolution due to overlapping peptides (Figure 2). High sequence coverage can 
be difficult to achieve in HX-MS studies, and coverage is often 50% or less, limiting the ability 
to survey events the entire protein.  Our analysis shows that sampling depth and search strategies 
are important factors to consider for maximizing sequence coverage. 
 
Amide hydrogen exchange in p38α  
p38α was incubated in D2O between 0-4 h and HX measurements were made on 101 
peptides (Figure 3).  Deuteration at 4 h was then measured for 29 peptides selected to provide 
highest coverage of residues without overlapping sequences which allowed us to evaluate the 
extent of hydrogen exchange in localized regions of the protein. These were mapped against the 
backbone structure of p38α (Figure 4A) 
Two regions of low hydrogen exchange (0-40%) were observed in p38α.  One was found 
in the C-terminal lobe, and included the active site β6 strand and helices αE and αF, which form 
helix interactions with each other and connect to the active site.  The second region included N-
terminal strands β3, β4, and intervening helix αC.  In contrast, high levels of exchange were 
observed in regions with high solvent accessibility, including the activation lip, the MAP kinase 
insert, and various loops including the Gly rich loop, which modulates ATP binding.  Thus, the 
HX measurements revealed slow exchanging core regions within both N- and C-terminal 
domains of the bilobed structure and faster exchange within peripheral regions and loops.  
Regions within the active site containing the conserved catalytic base (Asp150-Leu-Lys) and 
Asp168-Phe-Gly motifs exchanged more slowly than the activation lip and P+1 substrate 
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Figure 3.  Summary of HX-MS analyses of p38α.  Sequence coverage map of p38α, 
indicating residue numbering and secondary structures as reported (Wang et al., 1997; 
Wilson et al., 1996).  Observed peptides are shown as bars below the sequence, and are 
named according to residue number.  Peptides colored white show cases where hydrogen 
exchange rates were unaffected by phosphorylation and activation.  Peptides in green show 
cases where hydrogen exchange rates decreased significantly upon activation.  All peptides 
were observed in both 0P and 2P forms of p38α, except those outlined in bold, which indi-
cate those unique to 0P-p38α or 2P-p38α as indicated.
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Figure 4.  Regional hydrogen/deuterium in-exchange vs crystallographic B-factors.  
(A) Hydrogen exchange into 0P-p38α shows extent of deuteration after 4 h, normalized for 
each region by the number of exchangeable amides.  Colors distinguish regions deuterated 
to 0-20% (black), 21-40% (blue), 41-60% (teal), 61-80% (cyan), and 81-100% (white) of 
exchangeable amides.  (B) Normalized deuteration into 0P-ERK2 at 4 h, data from Hoof-
nagle et al. (2001).  (C,D) Crystallographic B-factors in p38α (1P38, Wang et al., 1997) and 
ERK2 (1ERK, Canagarajah et al., 1997).  Images were generated using PyMol 0.99
% Deuteration 0 20 40 60 80 100
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recognition site, the latter which underwent almost complete exchange in 4 h.  Overall, the 
pattern of regional hydrogen exchange was consistent with that expected from tertiary structure.   
 
Comparison of HX in p38α and ERK2 
HX measurements of p38α were compared to previous measurements of ERK2 
(Hoofnagle et al., 2001).  The extent of protein deuteration at 4 h was similar, respectively 
measured at 62% and 60% for p38α and ERK2.  In most regions, patterns of regional hydrogen 
exchange were similar between the two kinases.  Thus, in both p38α and ERK2, slower 
exchange was observed within the C-terminal core encompassing the catalytic site, αE, and αF, 
as well as the N-terminal core containing β3-αC-β4, while faster exchange occurred within 
peripheral regions and loops as well as the MAP kinase insert (Figure 4A,B). 
Two exceptions were helix αD and C-terminal helix αL16, where in each case the 
percentage deuteration in p38α and ERK2 differed by more than 40%.  In helix αD, 84% of 
exchangeable amides were deuterated after 4 h in p38α, in contrast to 39% in ERK2.  This 
correlated well with regional differences in main chain B-factors within helix αD, which were 
higher in p38α (37-76 Å2) than ERK2 (15-38 Å2) (Figure 4C,D).  Calculating the distance of 
each amide to the solvent accessible surface (distance-to-surface) as well as the length and 
orientation of amide hydrogen bonds showed similar structures and solvent accessibility of 
amide hydrogens within helix αD, between the two kinases.  This suggests that side chain 
interactions in p38α confer greater mobility within αD, whereas the same region is less dynamic 
in ERK2.   
Helix αL16 represents the C-terminal extension in MAP kinases, interacting with the N-
terminal lobe in a pocket formed between the β3-β4-β5 sheet and helix αC.  In p38α, helix αL16 
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exchanges slowly, with 10% deuteration after 4 h, whereas in ERK2, >58% of amides in the 
same region undergo deuteration.  This difference was not reflected by B-factors (Figure 4C,D), 
nor was it predicted from structure, where distance-to-surface and hydrogen bonding of amide 
hydrogens within αL16 showed very similar patterns between the two kinases.  We infer that the 
conformational mobility of αL16 in solution is significantly lower in p38α than in ERK2. 
Taken together, the hydrogen exchange measurements reveal that regional 
conformational mobility is conserved between p38α and ERK2 MAP kinases, reflecting 
conservation of sequence and tertiary structure.  Differences were noted in helix αD, where p38α 
showed higher mobility compared to ERK2, an effect recapitulated in B-factor measurements.  It 
was noteworthy that B-factors also predicted the high degree of hydrogen exchange observed 
within the activation lip of p38α, as well as the Gly-rich loop and other β-sheet loops within the 
N-terminus of both enzymes.  However, B-factors in αL16 were unable to predict differences in 
conformational mobility between p38α and ERK2, and were also inconsistent with high levels of 
hydrogen exchange observed within the activation lip and P+1 loop of ERK2, or the MAP kinase 
insert in either enzyme.  Overall, whereas the patterns of hydrogen exchange showed strong 
similarities between p38α and ERK2, the B-factor patterns appeared more divergent.    
 
Regional hydrogen exchange is altered by phosphorylation and activation of p38α. 
Hydrogen exchange measurements were compared between unphosphorylated (0P) and 
diphosphorylated (2P) forms of p38α, in order to define regions responsive to kinase activation.  
Sites of proteolytic cleavage were nearly identical between the two forms.  The sole exception 
was the activation lip, where several cleavage sites surrounding the Thr-Xxx-Tyr region in 0P-
p38α were masked from proteolysis in 2P-p38α (Figure 3).  This may be explained by altered 
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proteolytic specificity by phosphorylation, or conformational changes that convert a 
proteolytically accessible activation lip in 0P-p38α to a more protected conformation in 2P-
p38α.   
Of the 101 peptides, 32 showed significant differences in deuteration between active vs 
inactive p38α, where in all cases, HX decreased upon enzyme activation (Figure 3, indicated in 
green).  Many of these peptides overlapped in sequence, and in all, ten peptides were sufficient 
to summarize the changes in HX (Figure 5). 
Differences in HX either reflect changes in conformation upon p38α activation, or 
alternatively, report changes in conformational mobility and internal motions of the folded state.  
In order to evaluate contributions from structural changes, X-ray coordinates of 
unphosphorylated p38α (1P38, Wang et al., 1997) were compared to that of diphosphorylated 
p38γ (1CM8, Bellon et al, 1999) in regions where HX decreased upon p38α activation.  The lip 
and catalytic site structures in p38γ overlay well with those in diphosphorylated ERK2 and 
cAPK (Bellon et al., 1999), providing a reasonable prediction of how p38α would undergo 
conformational remodeling upon phosphorylation.  Outside the lip and catalytic site, backbone 
conformations of active p38γ and inactive p38α resemble each other closely, with rms deviations 
of 1.2 Å and 0.62 Å when N- and C-terminal domains are respectively superimposed between 
each enzyme (Bellon et al., 1999).  Thus, the difference in domain angle between these 
kinases reflects rigid body movements of the N- and C-terminal lobes. 
Peptides displaying the greatest changes in HX were located within five regions (Figs. 6-
10) For kinetic fits and error analysis of HX-MS data discussed see Tables 3 and 4:  
(1) Activation lip and P+1 specificity site.  Peptide residues (pr) 165-187 
(KILDFGLARHTDDEMTGYVATRW) contains the activation lip, with residues comprising 
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peptide 88-103
(β4-β5 loop)peptide 344-348
(C-terminal αL16)
peptide 72-87
(αC)
peptide
327-333
(C-terminal
3-10 helix)
peptide 
157-164
(β7-β8)
peptide
146-156
(β6)
peptide
165-187
(Activation lip)
peptide
130-145
(αE)
peptide
217-234
(αF-αG loop)
peptide
188-195
(P+1 loop)
Figure 5.  Summary of HX changes induced by p38α activation.  Represen-
tative peptides show regions significantly decreased in HX upon diphosphory-
lation of p38α, which are indicated in green on the main chain ribbon structure.
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the conserved Asp-Phe-Gly motif and Thr-Xxx-Tyr phosphorylation sites.  Here, the pepsin 
cleavage sites differed between 0P- and 2P-p38α (Figure 3).  Therefore, we compared the 
deuteration time course of pr165-187 observed as a single intact peptide in 2P-p38α to a 
corresponding time course calculated by summing deuteration of two peptides in 0P-p38α 
(Figure 6A).  The time course of pr165-182 + pr183-187 in 0P-p38α showed higher 
deuteration than peptide pr165-187 from 2P-p38α, despite the fact that the time course 
represented by composite sequences contained one less exchangeable amide. This confirms 
that HX decreases significantly within the activation lip in 2P-p38α.  Adjacent to this region 
is pr188-195 (YRAPEIML) which forms the P+1 substrate recognition site.  Direct 
comparison of the same peptide between 0P- and 2P-p38α revealed significantly decreased 
HX in active p38α (Figure 6B).  The X-ray structures of p38α and phosphorylated p38γ 
predict substantial conformational remodeling of this region upon kinase phosphorylation 
(Figure 6C).  In the 0P-p38α structure, residues 171-179 are highly exposed to solvent with 
large main chain B-factors (80 Å2), whereas in 2P-p38γ, the activation lip is more 
constrained with lower B-factors (45-70 Å2).  Residues within pr188-195, which are 
accessible to solvent in 0P-p38α, are buried in 2P-p38γ due to movement of the activation 
lip.  Such changes in conformation readily account for the significant decrease in HX 
observed in this region upon p38α activation.  Domain closure between N- and C-terminal 
lobes observed in 2P-p38γ may also reduce solvent accessibility of residues in the lip (Bellon 
et al., 1999).  Thus, the effect of p38α phosphorylation on hydrogen exchange occurring 
within the lip and P+1 loop can be attributed to structural remodeling of the activation lip as 
well as interdomain interactions which accompany dual phosphorylation. 
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Figure 6.  Comparison of peptide HX kinetics between 0P-p38a  (o) and 2P-p38a  
(▲) and associated X-ray structural differences in the activation lip and P+1 
substrate recognition site.  Time courses of deuteration are shown for (A) peptide 
region (pr) 165-187 in the activation lip and (B) pr188-195 in the P+1 site.  In 2P-p38α, 
the deuteration time course for pr165-187 is represented by a single intact peptide, 
whereas in 0P-p38α, the time course represents the sum of pr165-182 + pr183-187, 
which contains one less exchangeable amide than pr165-187 in 2P-p38α.  Nevertheless, 
the extent of deuteration decreases in 2P-p38α, reflecting a significant reduction in HX.  
(C) Cα conformation from X-ray structures of 0P-p38α (light green, 1P38) and 2P-p38γ 
(dark green, 1CM8), overlaying regions in the activation lip and P+1 site.  Amide 
hydrogens from p38α and p38γ are represented by yellow and black sticks, respectively.  
Arrowheads indicate peptide cleavage sites. 
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(2) C-terminal helix αE  and catalytic site β6.  Decreased HX was observed in pr130-145 
(LIYQILRGLKYIHSAD) which includes most of helix αE, and pr146-156 
(IIHRDLKPSNL) containing the β6-strand and catalytic base, Asp150 (Figure 7A,B).  Helix 
αE forms core α-helix interactions that stabilize the C-terminal domain, and residues in helix 
αE are deeply buried in p38α, with amide hydrogens typically removed from the surface by 
4-7 Å.  2P-p38γ shows no obvious changes in distance to surface or hydrogen bonding 
patterns in this region (Figure 7C).  Thus, the significant decrease in HX upon 
phosphorylation suggests lower conformational mobility in active p38α, enhancing stability 
of the C-terminal core.  Strand β6 forms interactions with the activation lip upon p38α 
phosphorylation, through ion pair interactions between Arg149 and lip residue pThr180, 
which may constrain mobility within β6 (Figure 7C). Side chain interactions between helix 
αE and strand β6 (Figure 7D) suggests connections between these regions that may explain 
their correlated decreases in HX. 
(3) C-terminal extension and the L16 loop.  pr327-333 (FESRDLL) in the p38α structure 
contains a single 3-10 helical turn at the end of the C-terminal extension, terminating in helix 
αL16, where HX decreases upon kinase activation (Figure 8A).  This region is disordered in 
2P-p38γ, thus structural comparisons cannot be made.  Nevertheless, much is known about 
this region, which has been implicated in p38α activation via a cluster of hydrophobic 
residues involving interactions between Phe327 located within this region and Tyr323 
located upstream, Trp337 in helix αL16 , and Tyr69 in helix αC (Figure 8B) (Diskin et al., 
2004; Diskin et al., 2007; Avitzour et al., 2007).  Studies by Diskin et al., (2007) have shown 
that mutating Phe327 to Leu or Ser causes p38α autoactivation by promoting 
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Figure 7.  HX-MS behavior and structural comparison in the C-terminal core region.  
Deuteration of (A) pr130-145, containing helix αE, and (B) pr146-156 containing β6 and the 
catalytic base, Asp150.  (C) Cα structures show similar conformation within αE between p38α 
(green) and p38δ (dark green). Residue Arg149 in β6 forms ion pair interactions with pThr180 in 
the activation lip of 2P-p38δ. Arrowheads indicate peptide cleavage sites. (D) Residue side 
chains between αE and β6 suggest potential interactions for coupling between these regions.
48
autophosphorylation at Thr180, and X-ray evidence shows that these mutations disrupt 
residue interactions within the hydrophobic cluster (Figure 8C, Diskin et al., 2007).  This in 
turn disrupts ion pair interactions of the adjacent residue Glu328 with Arg70 in helix αC, 
which in 0P-p38α are separated by 2.9 Å.  We speculate that release of Arg70 would enable 
rotation of helix αC, allowing formation of ion pair interactions with pThr180, as seen in the 
Arg70-pThr180 distance of 2.9 Å in 2P-p38γ (Figure 8C).  This model suggests that the 
hydrophobic cluster constrains interactions between helix αC and the activation lip by 
sequestering Arg70.  Therefore, it is reasonable to expect that phosphorylation of Thr180 at 
the activation lip would favor Arg70-pThr180 interactions, disrupting interactions between 
the hydrophobic cluster residues, and promoting interdomain closure.  We hypothesize that 
the observed decrease in HX in the 3-10 helix reflects conformational changes induced by 
remodeling of the hydrophobic cluster.   
The 3-10 helix in p38α resembles an analogous turn in the X-ray structure of 
phosphorylated ERK2 (Canagarajah et al., 1997).  In ERK2, the 3-10 turn is found uniquely 
in the phosphorylated kinase, and forms a surface for dimerization, where hydrophobic side 
chains in this region interdigitate with corresponding residues from a second subunit.  It has 
in fact been suggested that activating mutations facilitate p38α dimerization, given that 
autoactivation involves transphosphorylation between kinase subunits (Diskin et al., 2007), 
although no evidence for dimerization was apparent in the X-ray structure of 2P-p38γ or by 
size exclusion chromatography of 2P-p38α (Doza et al., 1995; Bellon et al., 1999). We 
therefore examined the possibility that p38α dimerizes following phosphorylation, and that 
the decrease in HX in pr327-333 might report steric protection from solvent in the dimer.  
Unphosphorylated and diphosphorylated forms of p38α were examined by sedimentation 
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Figure 8.  HX-MS behavior and structural comparison in the C-terminal extension 
3-10 helix.  (A) Deuteration of pr327-333, containing the 3-10 helical turn indicates a 
significant reduction in HX upon p38α activation. (B) Structure of p38α shows side 
chain interactions comprising a hydrophobic core region with side chain connectivities 
between helices αC, αL16 and the 3-10 helix.  Ion pair interactions with Glu328 
sequester Arg70 from interacting with activation lip residues. Pr327-333 is shown in 
green. (C) X-ray structure of p38α-Phe327Leu mutation (2FST, Diskin et al., 2004) 
revealing disrupted side chain interactions in the hydrophobic cluster and disruption of 
ion pair interactions between Arg70 and Glu328 (5.3 Å).  Rotation of Arg70 would 
enable new ion pair interactions between Arg70 and pThr180 (2.9 Å), which are observed 
in 2P-p38γ.  (D,E) Sedimentation equilibrium experiments carried out by analytical 
ultracentrifugation show that (D) 0P-p38α and (E) 2P-p38α are both monomeric.  The 
bottom panel shows absorbance units vs radius at 20,000 rpm (blue), 24,000 rpm (red) 
and 28,000 rpm (green).  The top panel shows residuals after fitting absorbance data to a 
single component model.  Weighted average masses 0P-p38α and 2P-p38α are 40,567 
Da and 42,784 Da, respectively (4-7% error). 
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equilibrium (Figure 8D,E).  Both forms of p38α were monomeric under all conditions.  Thus, 
wild-type p38α does not dimerize upon phosphorylation, and the decrease in HX in this 
region can instead be attributed to conformational changes in monomer. 
(4) N-terminal β4-β5 strands and helices αL16 and αC.  pr88-103 (DVFTPARSLEEFNDVY) 
contains strands β4-β5 and the intervening loop which is largely exposed to solvent.  Kinase 
activation leads to decreased HX in this region (Figure 9A).  Decreased HX is also observed 
in pr344-348 (EVISF) (Figure 9B), which represents the C-terminal helix αL16, a structural 
motif common to MAP kinase family members.  Peptide pr72-86 (LRLLKHMKHENVIGL), 
containing the αC-β4 loop, shows decreased HX whereas overlapping peptide pr75-86 does 
not (Figure 9C,D), indicating that the decreased HX can be narrowed to amide residues 72-75 
within helix αC (LRLL).  These regions form side chain interactions with each other within 
the N-terminal lobe, involving connections between Leu72 in helix αC, Val89, Leu96, and 
Phe99 in β4-β5, and Tyr342, Val345, Ile346, and Phe348 within αL16 (Figure 9E).  
Therefore, correlated decreases in HX in both regions may reflect coupling between these 
regions through hydrophobic side chain interactions Cα structures within this region show 
high overlap between 0P-p38α and 2P-p38γ (Figure 9F), suggesting that decreased HX may 
be accounted for by flexibility changes following phosphorylation, although perturbations in 
this region might also result from helix αC movements accompanying domain closure. 
(5) Substrate binding sites: strands β7-β8 and helices αF-αG.  pr217-234 
(LTGRTLFPGTDHIDQLKL) contains part of conserved helices αF and αG and the 
intervening loop, and forms an extended surface for interactions with the activation lip of the 
p38α substrate, MAPKAP kinase 2 (MK2) (ter Haar et al., 2007; White et al., 2007).  pr157-
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 Figure 9.  HX-MS behavior and structural comparison in the N-terminal core 
region of p38.  Deuteration of (A) pr88-103, containing β4-β5 and intervening loop, 
and (B) pr344-348 containing the C-terminal helix αL16.  Within the αC-β4 loop, 
(C) pr72-86 shows decreased HX and (D) pr75-86 shows no change, indicating that 
decreased HX can be localized to residues 72-75 (LRLL).  (E) Side chain 
connectivities between β4-β5, αL16, and αC, where regions with decreased HX are 
shown in green.  (F) Cα structures closely overlap between 0P-p38α (light green, 
light grey) and 2P-p38γ (dark green, dark grey), suggesting that the changes in HX 
reflect alterations in protein mobility rather than structure. 
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164 (AVNEDCEL) forms part of the binding site for a docking motif (“DEJL” motif) 
composed of a cluster of basic residues followed by L/I-X-L/I sequence, found in substrates 
and regulatory proteins, such as scaffold and adaptor proteins, MAP kinase kinases, and 
MAP kinase phosphatases (Tanoue et al., 2000; Chang et al., 20002). Both the αF-αG loop 
and the DEJL binding site form major contacts for binding p38α to MK2 (ter Haar et al., 
2007; White et al., 2007).  The interactions stabilize a high affinity inactive p38α-MK2 
complex, localized to the nucleus, which upon phosphorylation of p38α becomes disrupted, 
enabling phosphorylation and nuclear export of MK2 (ter Haar et al., 2007; Engel et al., 
1998).  αF-αG loop residue Thr218 also forms a partial interaction surface for the allosteric 
effector, TAB1, which selectively binds p38α through a modified docking interaction 
extending from this region to the nearby DEJL-motif binding site (Ge et al., 2002; Zhou et 
al., 2006a).   
In both regions, HX decreased upon p38α phosphorylation (Figure 10A,B).  Inspection of 
0P-p38α and 2P-p38γ showed little differences in structure within the αF-αG and β7-β8 loop 
regions (Figure 10C,D).  However in 0P-p38α, the activation lip residue Tyr182 makes close 
contacts with αF-αG loop residues Gly225-Thr226, burying the amide hydrogen at residue 
Thr226 (Figure 10C).  Remodeling of the activation lip in 2P-p38γ disrupts this interaction, 
exposing the amide to solvent.  Interestingly, HX decreased significantly in 2P-p38α, despite 
the predicted increase in solvent accessibility in this region upon kinase phosphorylation.  
The lack of concurrence between HX behavior and expected structural changes suggests that 
protein mobility in these regions decreases upon p38α activation, although structural 
differences between 2P-p38γ and 2P-p38α cannot be ruled out.  Conceivably, decreased 
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Figure 10.  HX-MS behavior and structural comparisons within substrate binding 
regions.   Time courses of deuteration for (A) pr217-234 in the αF-aG loop which comprises 
an extended substrate binding groove, and (B) pr157-164 in the β7-β8 loop which comprises 
part of the DEJL docking motif binding site. (C,D) Cα structures of 0P-p38α (light green) 
and 2P-p38δ (dark green), overlaying regions in the (C) αF-αG loop and (D) β7-β8 loop.
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flexibility within these binding sites might affect binding of substrate or TAB1 by reducing 
their interactions with the active form of p38α. 
 
Hydrogen exchange in monophosphorylated p38α. 
Phosphorylation of p38α occurs preferentially at Tyr182, and p38α-pTyr182 is the 
predominant monophosphorylated form in stress-treated cells and in vitro reactions with 
MKK3/6 (Doza et al., 1995; Raingeaud et al., 1995).  Therefore we examined HX behavior on 
p38α monophosphorylated at Tyr182 (0.85 mol/mol).  Figure 11 shows results for seven 
peptides where the largest change in HX was observed in active p38α, decreasing 
deuteration either by >50% or >2 Da over the time course.  In each case, time courses of 
deuteration in monophosphorylated p38α resembled those in unphosphorylated p38α more than 
diphosphorylated enzyme.  This occurred in the activation lip and P+1 site, as well as the 
substrate binding sites, the N- and C-terminal core regions, and the C-terminal 3-10 helix.  This 
indicates that the conformational and dynamic responses underlying the changes in HX result 
from phosphorylation at both Thr180 and Tyr182. 
 
DISCUSSION 
Hydrogen exchange measurements reveal information about conformational mobility of 
proteins in solution, and are complementary to structural analysis of low energy conformers by 
X-ray crystallography.  Analysis of p38α reveals slow exchanging core regions composed of β6, 
αE, and αF in the C-terminal domain and β3, β4 and αC in the N-terminal domain.  In contrast, 
greater levels of exchange were observed in the activation lip, the MAP kinase insert, and 
peripheral loops where the structure would predict higher solvent accessibility.  Thus, an 
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Figure 11.  HX-MS behavior of monophosphorylated p38α.  Deuteration time courses 
of peptides from p38α monophosphorylated at Tyr182 (●) are superimposed on time 
courses of 0P-p38α (ο) and 2P-p38α (▲).  In 1P-p38α, deuteration time courses of those 
peptides which significantly decreased in 2P-p38α, more closely resemble those of 0P-
p38α. 
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important finding from this study is that patterns of regional hydrogen exchange in p38α are 
consistent with tertiary structure.  With only a few exceptions, the HX patterns in p38α closely 
resemble those in ERK2, demonstrating that regional conformational mobility is conserved 
between these two MAP kinases, as one might expect based on their conserved sequences and 
tertiary structures.   
A key finding is that hydrogen exchange rates are altered in response to phosphorylation, 
reflecting changes in structure as well as conformational mobility upon kinase activation.  These 
can be interpreted by comparing X-ray structures of 0P-p38α and 2P-p38γ, and incorporating 
information from prior enzymatic studies.  Altered HX within the activation lip, P+1 loop, and 
active site (β6) are consistent with expected conformational remodeling of the activation lip 
following phosphorylation.  Likewise, changes in HX within the 3-10 helix most likely reflect 
conformational changes within an N-terminal hydrophobic cluster described by the Livnah group 
(Diskin et al., 2004; Diskin et al., 2007), which might undergo residue displacement upon 
activation lip phosphorylation.  In contrast, other regions show changes in HX that cannot be 
readily explained by structural rearrangements, and may instead reflect changes in protein 
internal motions or flexibility responsive to phosphorylation.  These are found in binding sites 
for substrates and allosteric regulators, N-terminal regions that link the core β4-β5 strand to 
helices αL16 and αC, and the C-terminal core helix αE.  Modulation of protein motions in these 
regions could contribute to kinase regulation, where decreased protein flexibility in localized 
regions might somehow facilitate substrate binding and turnover. 
HX behavior of 1P-p38α suggests a mechanism paralleling models of lip reorganization 
in ERK2.  X-ray structures of unphosphorylated and diphosphorylated ERK2 show stable 
activation lip structures (Zhang et al., 1994; Canagarajah et al., 1997), and enzymatic 
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measurements show that phosphorylation at Tyr185 is kinetically preferred (Haystead et al., 
1992).  In contrast, in X-ray structures of ERK2 mutants replacing the Thr-Glu-Tyr sequence at 
the activation lip with acidic residues, the activation lip becomes highly disordered (Zhang et al., 
1995).  Main chain B-factors increase by >35 Å2 and 55 Å2 in the structures of ERK2-Tyr185Glu 
and Thr183Glu/Tyr185Glu, respectively.  The results suggest that ERK2 undergoes 
phosphorylation at one residue (preferentially at Tyr) which increases mobility within the 
activation lip.  The lip then remodels into a stable active configuration following phosphorylation 
at the second residue.  Thus, both phosphorylation events are needed for the dramatic change in 
lip conformation during kinase activation.  In p38α, the activation lip is already disordered and 
highly exposed to solvent in the unphosphorylated form (Wang et al., 1997; Wilson et al., 1996).  
By analogy with ERK2, incorporation of one phosphate would produce little change in lip 
stability, until incorporation of the second phosphate tethers the lip into an active conformation.  
This would explain why HX of monophosphorylated p38α more closely resembles that of the 
unphosphorylated enzyme.  Our data suggests that hydrogen exchange in p38α is mainly 
regulated by conformational changes following dual phosphorylation, which anchor the lip into 
the active conformation.  
Importantly, patterns of hydrogen exchange regulated by activation show significant 
differences between p38α and ERK2.  As expected, both enzymes show perturbations within the 
activation lip, corresponding to lip remodeling.  In addition, both enzymes share patterns of 
decreased HX in the αF-αG loop region.  Regulated motions in this region may be important to 
modulate interactions between MAP kinase substrates as well as allosteric regulators, such as 
TAB1.  However, in contrast to p38α, ERK2 activation leads to increased HX within the hinge, 
Gly-rich loop, and MAP kinase insert (Figure 12).  Differences in HX regulation in 
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p38α ERK2
Figure 12.  Comparison of activation-induced changes in HX-MS in MAP kinases.  
Regulated HX in p38α from this study are compared to that of ERK2 from Hoofnagle 
et al. (2001).  Green indicates regions where HX decreases, red indicates regions where 
HX increases upon kinase activation, and black indicates missing sequence that could 
not be analyzed.  Yellow indicates the activation lip, where both increases and decreases 
in HX rates could be observed, ascribed to conformational remodeling upon activation.  
The result shows that conservation of sequence and tertiary structure does not lead to 
conservation of regulated conformational mobility.
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corresponding regions of p38α may reflect differences between these enzymes in mechanisms 
underlying enzyme activation.  For example, the ERK2 hinge represents a region of regulated 
flexibility which can be linked to interdomain interactions responsive to activity state (Lee et al., 
2005).  X-ray structures of inactive p38α show wider domain separation than ERK2, as well as 
hinge rotation allowing hinge residues to interfere with adenine ring interactions (Wang et al., 
1997; Wilson et al., 1996).  Thus, p38α retains an open conformation, even when bound to ATP-
competitive inhibitors or upon MK2 substrate binding (ter Haar et al., 2007; White et al., 2007; 
Wang et al 1998). Such constraints prevent domain closure, and probably preclude regulation of 
HX upon activation lip phosphorylation.  As a result, ATP binding affinity increases 
substantially upon activation of p38α (also seen in p38γ), whereas ERK2 shows little change in 
ATP binding upon activation (Zhang et al, 1994; Lee et al., 2005; Frantz et al., 1998; Fox et al., 
1999).  
The ability to monitor protein flexibility and mobility by HX adds a new dimension 
towards understanding how kinases are controlled.  The regulated motions revealed by HX 
alterations upon kinase activation are dissimilar between ERK2 and p38α, which are closely 
related in sequence, tertiary structure, and dual phosphorylation mechanism.  We conclude that 
while patterns of solvent accessibility may be conserved between related enzymes, patterns of 
activation-induced motional changes are not conserved.  Our findings provide evidence that 
MAP kinases diverge with respect to regulation of internal protein motions and their potential 
contribution to function. 
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CHAPTER III 
 
Hinge Flexibility Controls Interdomain Closure in ERK2 
 
INTRODUCTION 
HX-MS has been used to examine properties of enzyme activation, regulated 
conformational mobility, and substrate binding in the MAP kinase, ERK2, where distinct 
differences in regional hydrogen exchange rates can be observed between inactive 
(unphosphorylated) and active (diphosphorylated) states of the enzyme (Hoofnagle et al., 
2001). Altered HX was observed in the activation lip, as expected from the 
conformational reorganization which follows phosphorylation.  Increased HX also occurs 
within the conserved glycine-rich ATP binding loop, and within the hinge region between 
N- and C-terminal domains.  These could not readily be accounted for by differences in 
X-ray structure between active and inactive ERK2, suggesting that phosphorylation and 
activation of this enzyme regulates backbone conformational mobility in key regions of 
this enzyme.  For example, increased conformational mobility at the hinge might enable 
domain closure needed for catalysis. 
Follow up experiments were conducted to test this hypothesis.  First, site directed 
spin label-electron paramagnetic resonance spectroscopy (SDSL-EPR) was carried out on 
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ERK2, in which cysteine residues were individually engineered at different regions of the 
hinge onto which nitroxide spin label groups were added (Hoofnagle et al., 2004). 
Residues at the hinge showed significant changes in correlation rate without evidence for 
conformational perturbations, consistent with altered side chain dynamics at the hinge 
upon ERK2 activation.  Second, HX-MS was used to monitor binding of a 
nonhydrolyzable nucleotide analog, AMP-PNP, to active and inactive forms of ERK2 
(Lee et al., 2005). In inactive ERK2, Mg2+-AMP-PNP binding caused steric protection 
from deuteration in regions within the N-terminal domain that were known to interact 
with nucleotide, including the glycine-rich loop, sheet β3/helix αC, and the hinge region, 
but little protection within the C-terminal domain.  In contrast, nucleotide binding to 
active ERK2 led to comparable protection in N-terminal regions and the hinge, but 
increased protection around the Asp-Phe-Gly (DFG) motif in the C-terminal domain. 
Both forms of ERK2 bound Mg2+-AMP-PNP with similar affinity as measured by 
isothermal titration calorimetry.  The findings led to novel insight into the solution 
conformation of ERK2, by demonstrating that the inactive enzyme is constrained from 
forming a closed domain solution conformation needed for catalysis, which the active 
state is able to adopt.   
The results are consistent with a model in which the increased flexibility at the 
hinge induced by phosphorylation allows ERK2 to overcome a barrier to interdomain 
closure, which is needed in order to form a competent catalytic site. In this way, the 
mechanism of activation may in part involve regulation of hinge flexibility, reflecting 
dynamical control of ERK2 activity. However, the results so far only demonstrate 
correlations, and stop short of proving causality.  An alternative interpretation is that the 
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changes in conformational mobility at the hinge observed in HX-MS studies are not 
coupled to domain closure.  In fact, one could imagine instead that phosphorylation 
drives domain closure, which then leads to enhanced hydrogen exchange within the 
hinge, not the other way around.   
The goal of this study is to test the hypothesis that interdomain closure can be 
regulated by hinge flexibility, by introducing glycine substitutions at various hinge 
residues which would be expected to increase flexibility, and asking whether these lead to 
domain closure. We focused on a region containing residues 105LMETD109, which in 
ERK2 increases conformational mobility following kinase activation, and corresponds to 
the region which serves as the pivot point for hinge bending during domain closure in 
cAMP-dependent protein kinase. Here we show that replacing residues within the hinge 
region of the unphosphorylated form of ERK2 with Gly-Gly promotes domain closure, as 
measured by HX protection by AMP-PNP binding within the conserved DFG region of 
the C-terminal domain. The results demonstrate that increasing hinge flexibility can 
promote domain closure, and provide new evidence supporting my hypothesis that hinge 
mobility regulated by activation lip phosphorylation may be crucial for the mechanism of 
kinase activation.   
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MATERIALS & METHODS 
Protein expression and purification 
ERK2 mutants introducing Gly-Gly substitutions at hinge residues, 105LM106, 
106ME107, 107ET108, and 108TD109, were made as described (Emrick et al., 2006). Inactive 
wild-type ERK2 (0P-ERK2) and mutants were prepared as described with the following 
changes (Robbins et al., 1993). Cells expressing 0P-ERK2, 106ME/GG, and 107ET/GG 
were grown at 30 °C to O.D.(600 nm) 0.5-0.6, at which point they were rapidly chilled by 
placing into an ice-water slurry for 15 minutes. IPTG (isopropyl β-D-1-
thiogalactopyranoside, 0.4 mM) was then added and proteins were induced for 6 hours at 
23 °C. Active ERK2 (2P-ERK2) was expressed using the dual expression plasmid, 
NpT7-5 MEK1R4F-His6-ratERK2 (Wilsbacher & Cobb, 2001; Goldsmith et al., 2004), in 
E. coli BL21 (DE3)-pLysS (Invitrogen, Carlsbad, CA) grown in 1 L Terrific Broth at 37 
°C, reaching O.D.(600 nm) 0.3-0.4 before induction with 0.4 mM IPTG for 6 hours.    
Additional mutants of ERK2 were prepared by combining hinge mutations 
(substituting 105LM106, 106ME107, 107ET108, and 108TD109 with Gly-Gly) and activation lip 
mutations (Thr183 and/or Tyr185 to Glu, Asp, or Phe) generated in NpT7-5 His6-ratERK2 
(primers listed in Appendix A). Plasmids were transformed into E. coli BL21 (DE3) 
pLysS and the proteins were purified from 200 mL of bacterial culture as described 
above.  
For HX-MS experiments, proteins were produced in 1 L bacterial culture and 
purified first with Ni2+-NTA agarose (1 mL, Qiagen, Valencia, CA), followed by Mono 
Q FPLC as described (Emrick et al., 2006; Lee et al., 2005). After Mono Q elution, 
proteins were dialyzed into 10 mM potassium phosphate pH 7.5, 50 mM KCl, 1 mM 
65
DTT and stored in 65 μL aliquots at -80 °C.  Mass spectrometry confirmed 
phosphorylation stoichiometry at the activation lip as ≥ 95% diphosphorylated for 2P-
ERK2 preparations, and ≤ 5% diphosphorylated + monophosphorylated for the 0P-ERK2 
and mutant ERK2 preparations (Table 1). 
For kinase activity assays, ERK2 proteins were induced in 200 mL of bacterial 
culture as described (Emrick et al., 2006). Purified protein was eluted from Ni2+-NTA 
agarose (200 μL) in 50 mM potassium phosphate (pH 8.0), 0.3 M NaCl, 1 mM DTT, 0.3 
M imidazole.  Fractions containing protein were pooled, dialyzed into 10 mM Hepes, pH 
7.5, 0.1 M NaCl, 1 mM DTT, and frozen in aliquots at -80 °C. 
 
Hydrogen-exchange mass spectrometry (HX-MS) measurements 
ERK2 was incubated in 85% (v/v) D2O between 0 - 4 hours, and HX data 
collection was performed as described (Lee et al., 2005) using a QStar Pulsar QqTOF 
mass spectrometer interfaced with an Agilent Cap1100 HPLC (500 μm i.d. x 10 cm 
column, packed with POROS R1 20 resin).  Time-zero measurements were performed to 
measure background in-exchange during proteolysis, by acidifying the reaction before 
adding D2O.  Time points were randomized to control for systematic variations.  Three 
replicate runs of each ERK2 form were performed at 1 min, in order to determine average 
standard deviation of deuteration for all peptides (0.12 Da) (Table 2). 
Weighted average mass (WAM) calculations were carried out using in-house 
software for semi-automated analysis (HX-Analyzer, Sours et al., 2008). Deuteration 
measurements were corrected for artifactual in-exchange, back-exchange, and fit by 
nonlinear least squares (NLSQ) to the equation Y = N – Ae -k1t – Be –k2t – Ce –k3t, where 
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Table 1: Phosphorylation stoichiometry for the activation lip TEY 
residues for proteins analyzed by HX-MS
% diphosphorylated% monophosphorylated% unphosphorylated
2P 95 2 3
0P 0 3 97
LM 0 0 100
ME 0 1 99
ET 0 1 99
TD 2 0 98
Notes
2P is ≥ 95% phosphoylated on both TEY residues
0P and the mutants are ≥ 95% unphosphorylated on both TEY residues 
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Y is the number of deuterons exchanged at time t, A, B, and C are the number of 
backbone amides exchanging with rate constants k1, k2, and k3, and N is the maximal 
deuteration over the experimental time period (N = A + B + C).  Subtracting N from the 
total number of exchangeable backbone amides yields NE, the number of amides that are 
non-exchanging over the experimental time period (Hoofnagle et al., 2003; Hoofnagle et 
al., 2004b; Lee et al., 2006).   Non-linear least squares curve fitting was performed and 
results plotted using SigmaPlot 9.0 software (Systat Software, Inc.).  
For LC-MS/MS, proteins incubated in water were treated and proteolyzed as 
above.  Samples (5 μg) were analyzed on the QStar mass spectrometer with m/z window 
= 400-1600 Da, duty cycle 15.5 seconds, and 3 MS/MS per cycle.  Samples (60 ng) were 
analyzed in parallel by LC-MS/MS on a LTQ-Orbitrap mass spectrometer interfaced with 
an Eksigent 2DLC HPLC (75 μm i.d. x 150 mm column, Zorbax C18 resin), with m/z 
window = 300-2000 Da, duty cycle 4-6 seconds (~10-14 cycles/minute), and 5 MS/MS 
per cycle.  Peptides were identified by converting MS/MS spectra to .mgf files and 
searching against wild-type or mutant rat ERK2 sequences using the Mascot search 
program (v.1.9), with “no enzyme” specificity.  Mass tolerances used for Pulsar datasets 
were 2.5 Da for parent ions and 1.2 Da for fragment ions.  Mass tolerances for LTQ-
Orbitrap datasets were 1.2 Da for parent ions and 0.8 Da for fragment ions.  The score 
threshold used for high confidence identifications was Mowse ≥ 30. 
 
Protein kinase assays 
Activities of 0P-ERK2, hinge mutants and combination mutants (2 μg) were 
measured by phosphorylation of bovine myelin basic protein (MBP, 2 μg, Sigma, St. 
76
Louis, MO) for 1 hour (combination mutants) or 2 hours (0P, hinge mutants) at 30 °C, 
and activity of 2P-ERK2 (1 ng) was measured using 5 μg rabbit MBP for 5 minutes at 30 
°C.  Kinase assay reactions were initiated by addition of 5x reaction buffer [125 mM 
Hepes, 50 mM MgCl2, 10 mM DTT, 1 mM ATP, and 50 μL [γ-32P] ATP (10 mCi/mL)] 
to a final volume of 25 μL. IC50 measurements were made performed in the presence of 
AMP-PNP varying between 0-20 mM. Reactions were quenched by spotting 20 μL onto 
P81 paper strips (Whatman), which were washed in 1% (v/v) phosphoric acid and 
quantified by scintillation counting. Curves were fit using SigmaPlot 9.0 software (Systat 
Software, Inc.) and IC50 concentrations were determined according to the following 
equation with log scale on the X axis  
Y = min + (max-min) / (1 + (x / IC50) ^ Hillslope)   (1)  
 
Isothermal titration calorimetry (ITC) 
 AMP-PNP was dissolved to 5 mM in the same buffer used for purification of 
ERK2 (50 mM Tris pH 7.5, 150 mM NaCl, 5 mM MgSO4, 2% (v/v) glycerol, 0.1% (w/v) 
EDTA). An ITC 200 (Microcal) calorimeter was used to titrate AMP-PNP (28 injections, 
each 1.37 μL) into 0P-ERK2 (50 μM) at 10 °C. Blank runs were performed without 
ERK2, subtracted from experimental runs, the thermogram was integrated, and Kd values 
were estimated using Origin 7.0 software.  
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RESULTS 
HX-MS peptide coverage 
 HX-MS was used to analyze six forms of ERK2, including unphosphorylated (0P) 
and diphosphorylated (2P) wild type ERK2, and mutants incorporating Gly-Gly 
substitutions in the hinge region (105LMETD109), including 105LM106 /GG, 106ME107/GG, 
107ET108/GG, and 108TD109/GG (Figure 1).  Thirty-one peptides were identified from wild-
type 0P-ERK2 after pepsin digestion, covering 91% of residues in ERK2 and 87% of 
exchangeable amides (Figure 2, Table 2 & 3). Differential cleavage was observed in the 
phosphorylated activation lip of 2P-ERK2, as previously noted (Hoofnagle et al., 2001; 
Lee et al., 2005).  In each of the four hinge mutants, the peptides produced from the 
activation lip were identical to those in 0P-ERK2.  Pepsin cleavages in the hinge region 
varied between mutants (Tables 2 & 3), but all mutants generated longer peptides 
containing residues 101 to 110, corresponding to the hinge region of wild type ERK2, 
101IVQDLMETDL110.  Wild-type ERK2 and mutant TD/GG each generated a peptide 
containing the N-terminal hinge residues, 101IVQDL105, whereas wild-type and mutants 
ME/GG and TD/GG generated a peptide containing the C-terminal hinge residues, 
106METDL110. 
 
Evidence for native folding of the ERK2 hinge mutants 
 In order to compare folding in solution between wild-type ERK2 and hinge 
mutants, the extent of deuteration at the longest time point was measured in different 
regions of each enzyme.  Figure 3 shows the deuteration at 4 hours for each protein form, 
normalized by the number of exchangeable amides and mapped against the X-ray 
78
DLMETDL
GG
GG
GG
GG
1
2
3
4
104 110
KICDFGL161 168
Figure 1: Outline of an experimental strategy to test the effects of increased 
hinge flexibility on domain closure as measured by protection from hydrogen 
exchange in the C-terminal domain. Four Gly-Gly mutations (labeled on the left) 
were engineered in the hinge region (shown in blue) in order to increase backbone 
flexibility.  Previous studies (Lee et al., 2005) established that domain closure can be 
monitored by increased HX protection in the conserved DFG region of the C-terminal 
domain (shown in orange, sequence indicated on the right). 
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MAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKI
10                                          20                                         30                                        40                                         50                                         60                                        70
β1LO β2LO β1 β2 β3 αC
LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVL 
   80                                         90                                        100                                       110                                      120                                      130                                       140  
β4 β5 αEαD
AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 
   220                                      230                                       240                                     250                                      260                                      270                                      280  
αG αHα1L14 α2L14
LDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS 
  290                                      300                                      310                                      320                                      330                                      340                                      350  
αL16αI
HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCIL
   150                                      160                                       170                                      180                                       190                                      200                                       210  
β6 β7 β8 β9 αF
5-26
18-26
27-40
39-44
45-69
70-86 87-100
87-98
101-105 105-110
101-110
111-126 131-144
145-153
154-160
155-161
161-168
162-168
162-181
169-190
185-190
186-190
191-197 199-213
220-248 253-262 263-286
292-305 314-333 334-346 347-358
Figure 2: Summary of peptides monitored in our HX-MS analyses of ERK2. Sequence 
coverage map of ERK2, indicating residue numbers and secondary structures as reported 
(Zhang et al, 1994).  Observed peptides are shown as bars below the sequence and are named 
according to residue number.  Peptides colored grey were found in all six proteins and were 
analyzed as described in Materials and Methods. Peptides that are unique to certain kinase 
forms, and produced by differential proteolysis are colored as follows: Orange: unique to phos-
phorylated (2P); Green: unique to unphosphorylated (0P). Peptides showing differential prote-
olysis between wild type and mutant kinases within the hinge region are colored as follows:  
Pink: Unique to wild type and mutant TD/GG; Cyan: Unique to wild type, ME/GG, and 
TD/GG; Yellow: Unique to 0P- and 2P-ERK2 (WT).
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2P 0P LM/GG
ME/GG ET/GG TD/GG
Figure 3: Hydrogen exchange in different forms of ERK2. Colors reflect the extent of 
deuteration at 4 hours, normalized for each peptide by the number of exchangeable amides and 
multiplied by 100.  X-ray structures were PDB:1ERK, for 0P-ERK2, LM/GG, ME/GG, ET/GG, 
and TD/GG (Zhang et al.1994), and PDB:2ERK for 2P-ERK2 (Canagarajah et al.1997). The 
color coding is Black: 0-25%, Blue: 26-50%, Teal: 51-75%, and White: 76-100%. Similar HX 
patterns are observed between wild type and mutant kinases, indicating comparable solution 
structure and folding.
% Deuteration 0 25 50 75 100
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structures of ERK2 (Zhang et al., 1994; Canagarajah et al., 1997).  The 0P and 2P forms 
of wild-type ERK2 showed similar patterns of deuteration which was low in core regions 
of N- and C-terminal domains and higher in peripheral regions and loops (Figure 3). 
These repeated the patterns reported previously by Hoofnagle et al. (2001). Similar 
patterns were also observed in each of the hinge mutants (Figure 3). Thus, the extent of 
deuteration reached only 7% in the solvent protected αE-β6 core region of the C-terminal 
domain, which is known to be stabilized by extensive hydrogen bonding interactions, 
whereas deuteration reached 91% within β1LO-β2LO in the N-terminal domain which is 
highly solvent exposed. The similar extent of hydrogen exchange between all six proteins 
suggested comparable solvent accessibility for each, and argued against extensive 
unfolding introduced by mutagenesis. Likewise, evidence for bimodal HX patterns, 
which occur when proteins are partially unfolded, was absent in all datasets.  
 
Differential effects of AMP-PNP binding on HX patterns in mutant forms of ERK2 
 We next asked whether the Gly-Gly mutations at the hinge region altered 
interdomain interactions in ERK2.  Upon AMP-PNP binding, steric protection from 
solvent leads to reduced HX in regions of 0P-ERK2 and 2P-ERK2 containing the Gly-
rich loop, the conserved Lys-Glu ion pair within β3-αC-β4, the hinge region, and the 
catalytic base; all of which are known to form close interactions with nucleotide.  In 
addition, 2P-ERK2 shows greater protection from HX than 0P-ERK2 within the 
conserved DFG motif, part of the C-terminal domain which forms metal coordination 
interactions with Mg+2-ATP. Thus, AMP-PNP-dependent protection from HX in the DFG 
83
motif provides an indirect assay for interdomain closure.  We applied this assay to 
measure domain closure in ERK2 mutants containing Gly-Gly substitutions at the hinge.  
Figure 4 summarizes different forms of ERK2, indicating regions where altered 
HX were observed upon AMP-PNP binding.  Regions in green showed reduced HX upon 
nucleotide binding, regions in red showed increased HX upon binding, and regions in 
grey showed no change. Overall, most regions showed little difference in HX rates 
between bound and unbound states, as shown by time courses for representative peptides 
in each protein (Figure 5).  However, every wild type and mutant protein showed 
protection from HX within regions known to form the ATP binding site, including the 
Gly-rich loop, hinge, β3-αC-β4, and the DFG motif, as noted previously for 0P- and 2P-
ERK2 (Lee et al., 2005) (Figures 6-8).  The exception was the mutant ERK2-LM/GG, 
which showed no protection at all in any region, suggesting that the mutations disrupted 
nucleotide binding without grossly altering the protein solution structure.  Figure 6 
showed decreased in-exchange in the Gly-rich loop (27SYIGEGAYGMVCSA40) with 
maximal HX protection by nucleotide binding of ~1 Da in every protein.  Figure 7 shows 
protection in a peptide spanning β3 and the N-terminus of helix αC 
(45NKVRVAIKKISPFEHQTYCQRTLRE69) which contains the conserved 52Lys and 
69Glu residues known to coordinate the α and β phosphoryl groups in ATP, and an 
adjacent peptide spanning the C-terminus of helix αC and β4 
(70IKILLRFRHENIIGIND83). Peptide 45-69 previously was reported to show a minor 
decrease in HX (0.5 Da upon AMP-PNP binding) with little change in peptide 70-83.  
However, in my hands, decreased HX in peptide 45-69 was seen only in the mutants 
ERK2-ME/GG and ET/GG, and not in the wild-type proteins, while peptide 70-83 
84
2P 0P LM/GG
ME/GG ET/GG TD/GG
Figure 4: Changes in hydrogen exchange upon AMP-PNP binding in different forms of 
ERK2. Regions corresponding to peptides showing reduced deuteration upon AMP-PNP binding 
(1 mM) are colored green. Regions corresponding to peptides showing increased HX upon AMP-
PNP binding are colored red.  Mutant LM/GG shows little HX protection at all, reflecting low 
nucleotide binding affinity.  The changes due to AMP-PNP binding are mostly localized around 
the active site, where nucleotide binding would be expected to provide steric protection from 
hydrogen exchange. PDB structures used were as described in Figure 3. 
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Figure 5:  Effect of AMP-PNP binding on HX in a region of ERK2 outside the 
nucleotide binding interface. Deuteration time courses for the peptide, IIRAP-
TIEQMKDVY, located in strands β4-β5 in the N-terminal domain and not predicted 
to be directly involved in nucleotide binding.  As expected, time courses of deuterium 
incorporation were comparable between experiments in the presence and absence of 1 
mM AMP-PNP. This indicates that AMP-PNP binding does not introduce nonspecific 
global effects on structure, and that the hinge mutations do not perturb hydrogen 
exchange behavior in this region.
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Figure 6:  Effect of AMP-PNP binding on HX in the Gly-rich loop region. 
Deuteration time courses for the peptide, SYIGEGAYGMVCSA, located in the 
Gly-rich loop, which in protein kinases forms backbone atom contacts with 
bound ATP.  As expected, partial HX protection upon AMP-PNP binding is 
found in all wild type and mutant ERK2 proteins.  The exception is mutant 
LM/GG, which shows little HX protection upon AMP-PNP binding in this and 
other regions, consistent with low nucleotide binding affinity.
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Figure 7: Effect of AMP-PNP binding on HX of peptides representing β3-αC-β4.  
Deuteration time courses of peptide 45NKVRVAIKKISPFEHQTYCQRTLRE69 residing 
in N-terminal strand β3 and helix αC, which contains a conserved glutamic acid residue 
(E69) and is involved in coordinating ATP.  Peptide 70IKILLRFRHENIIGIND86 resides 
in helix αC and strand β4, immediately following the conserved glutamic acid. ME/GG 
and ET/GG mutants show protection in β3/αC while 0P- and 2P-ERK2 show protection 
in αC/β4 suggesting finite but weak interactions with AMP-PNP throughout the 
β3/αC/β4 region.
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Figure 8: Effect of AMP-PNP binding on HX of peptides corresponding to the hinge 
region. A. Deuteration time courses of peptides corresponding to positions 101-110 in the 
hinge between β5-αD (101IVQDLMETDL110 in WT) are present and show HX protection 
by AMP-PNP binding in all ERK2 proteins except mutant LM/GG.  B. Peptides corre-
sponding to positions 101-105 (101IVQDL105 in WT) are observed in 0P- and 2P-ERK2 
and mutant TD/GG.  C. Peptides corresponding to positions 106-110 (106METDL110 in 
WT) are observed in 0P- and 2P-ERK2 (top graphs) and mutant ME/GG (bottom left).  
Mutant TD/GG shows a different cleavage product corresponding to positions 105-110 
(105LMETDL110 in WT). The ME/GG and TD/GG graphs show 2P in black, 0P in red and 
the hinge mutant colored, ME/GG: teal and TD/GG: purple. 
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showed minor protection in all forms except mutant TD/GG. This suggests that AMP-
PNP coordinates this N-terminal region and provides some steric protection from HX, but 
felt throughout αC and with some variation in amide localization.  
 In addition, two proteins showed evidence for increased HX.  One region was 
located N-terminal to the Gly-rich loop outside the kinase consensus core 
(18DVGPYTNL26), as observed in 2P-ERK2 and the TD/GG mutant.  The other region 
was localized to a loop (292LTFNPHKRIEVEQA305) between helices αH and αI in the C-
terminal domain in 2P-ERK2. These increases were unexpected, because they were not 
observed previously for 2P-ERK2, and will require further investigation to fully 
understand. However, we conclude that the results for the most part revealed reduced HX 
in regions that were consistent with binding of AMP-PNP to the ATP binding site in wild 
type and mutant forms of ERK2. 
 
Evidence for nucleotide binding and HX protection in the hinge region 
 The Gly-Gly mutations introduced altered proteolysis in the hinge region, 
resulting in variable peptides from those observed in wild type forms of ERK2, and in 
some cases, failure to observe related peptides. For example, while all forms generated 
cleavage products corresponding to hinge peptide 101IVQDLMETDL110 (wild-type 
sequence), only the wild-type proteins and the TD/GG mutant generated the N-terminal 
hinge peptide, 101IVQDL105, while ME/GG generated the C-terminal hinge peptide, 
106GGTDL110, and mutant TD/GG generated an alternative proteolytic product, 
105LMEGGL110 (see Tables 2 and 3).  
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 Figure 8 details time courses observed in the hinge region for wild type and 
mutant proteins. For the peptide containing the entire hinge (corresponding to 
101IVQDLMETDL110  in the wild-type sequence), each mutant protein showed similar 
levels of overall deuteration (3.0-3.7 Da), comparable to those in wild type ERK2 (Figure 
8A). Protection from HX upon AMP-PNP binding was observed in all mutants except 
LM/GG, although the magnitude of protection was lower than that of 0P-ERK2 or 2P-
ERK2. The HX behavior suggested that each mutant bound AMP-PNP in the hinge 
region, but allowed higher accessibility to solvent penetration in the bound states, 
consistent with greater flexibility introduced by the Gly-Gly mutations.   
In the shorter N- and C-terminal hinge peptides (101IVQDL105, corresponding to 
106METDL110 in the wild-type sequence), HX behavior in 0P- and 2P-ERK2 showed 
similar behavior to that observed previously in our lab (Hoofnagle et al., 2001; Lee et al., 
2005). Peptide 101IVQDL105 in mutant TD/GG provides the only direct comparison with 
the mutant forms, and shows faster HX than wild-type proteins, with comparable HX-
protection upon nucleotide binding.   
 
Evidence for domain closure in hinge mutants 
 Previous studies suggested that interdomain closure could be reflected by 
enhanced HX protection in 2P-ERK2 compared to 0P-ERK2, of a peptide containing the 
conserved DFG motif within the C-terminal domain (162KICDFGL168) (Lee et al., 2005).  
It is this metric that I used to assay for domain closure in the hinge mutants. Figure 9 
shows the same peptide, found in all six proteins compared in this HX-MS study. HX 
behavior in 2P and 0P recapitulated the result from Lee et al. (2005), with increased HX 
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Figure 9: Effect of AMP-PNP binding on HX in the conserved DFG region. 
Deuteration time courses of peptide 162KICDFGL168 containing the conserved 
DFG sequence.  All ERK2 proteins show similar deuteration in this region in 
absence of AMP-PNP, but vary in HX protection in the presence of AMP-PNP.  
0P-ERK2 and mutant TD/GG show less protection when bound to AMP-PNP, 
while ME/GG and ET/GG show greater HX protection, similar to that observed 
in 2P-ERK2.  LM/GG shows no HX protection, consistent with low nucleotide 
binding affinity.   
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protection in 2P-ERK2 bound to AMP-PNP compared to 0P-ERK2. In addition, 2P-
ERK2 showed a slower rate of overall deuteration in the unbound state, as previously 
observed, hinting that this form may be less solvent accessible due to partial closure in 
absence of nucleotide. My results were consistent with previous conclusions suggesting 
that 2P-ERK2 adopts a more closed conformation in solution compared to 0P–ERK2, and 
suggesting that phosphorylation overcomes a constraint to domain closure.  
All ERK2 mutants showed overall deuteration into 162KICDFGL168 (1.4-1.5 Da) 
comparable to that of the wild-type proteins. HX protection upon AMP-PNP binding was 
observed in ME/GG, ET/GG and TD/GG mutants.  Importantly, mutant ME/GG showed 
maximal HX reaching 0.6 Da in the bound state, which was comparable to that of 2P-
ERK2.  In contrast, mutants ET/GG and TD/GG showed maximal HX reaching 1.3 Da in 
the bound state, comparable to that of 0P-ERK2.  Furthermore, HX rates in the bound 
state were slower in ET/GG than TD/GG.  Taken together, my results indicate that 
introduction of Gly-Gly mutations in the hinge region can recapitulate behavior seen 
upon phosphorylation and activation of ERK2, and suggest that ME/GG adopts a bound 
conformation consistent with domain closure in 2P-ERK2, while TD/GG is constrained 
from closure as in 0P-ERK2, and ET/GG adopts a partially closed state intermediate 
between ME/GG and TD/GG.  The results argue that mutations which would be expected 
to enhance flexibility in the hinge appear to enhance interdomain interactions in ERK2.  
 
IC50 concentrations report similar binding affinity among ERK2 proteins 
 The time courses shown above showed that all mutants, except LM/GG, bound 
AMP-PNP with similar degree of protection from HX to that of 0P-ERK2 and 2P-ERK2 
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(Figures 6 & 7), suggesting that the binding affinities are comparable between mutant and 
wild-type proteins. However, direct measurements of the mutations on binding affinity 
have not been tested directly. In order to address this, I have tested two approaches, one 
comparing inhibition of initial rate measurements by AMP-PNP, and the other using 
isothermal titration calorimetry (ITC) to measure equilibrium dissociation constants for 
AMP-PNP binding.  
 I first measured initial rates for phosphorylation of myelin basic protein (MBP) by 
phosphoryl transfer from [γ-32P]ATP, catalyzed by wild-type or mutant forms of ERK2.  
Initial rates normalized to total enzyme are plotted vs [AMP-PNP] in Figure 10, 
indicating the best fit IC50 values for each protein. IC50 reports the concentration of an 
inhibitor that will produce 50% inhibition of the enzyme activity, which is related to 
inhibitor dissociation constant (Ki) by the following relationship: 
  IC50 = Ki (1 + S / Km)      (2)  
where S is the substrate concentration and Km is the Michaelis constant (Cheng & 
Prusoff, 1973).  In my experiments, [MBP] and [ATP] were held constant at 25 μM and 
200 μM, respectively, with rate measurements carried out at 30 ºC.  Therefore, the IC50 
measurements are not necessarily proportional to Ki in all cases unless Km is also 
constant between different protein forms. But it was reasonable to begin with this 
approximation, in carrying out the initial experiments. 
IC50 values measured for wild-type ERK2 were 194 ± 25 μM for 0P-ERK2 and 
366 ± 47 μM for 2P-ERK2, while IC50 values for mutants LM/GG, ME/GG, ET/GG and 
TD/GG were respectively 176 ± 21 μM, 356 ± 30 μM, 280 ± 31, and 298 ± 20 μM 
(Figure 10). On the surface, the results suggest that all of the mutants showed comparable 
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Figure 10: Specific activity and IC50 measurements for wild type and 
mutant forms of ERK2. Specific activity (pmol/min/mg) was measured in the 
presence of varying AMP-PNP concentrations as described in Materials and 
Methods.  Curves were fit by non-linear least squares to equation (1).  Fitted 
IC50 values and standard deviations are indicated for each protein.
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affinity for AMP-PNP under the reaction conditions. However, the IC50 was comparable 
even for mutant LM/GG, which was surprising, given the absence of HX protection by 
AMP-PNP for this protein form (Figure 4). This suggested the potential for 
misinterpretation of the IC50 measurements.   
I can explain these apparently contradictory results in the following way. 
Phosphorylated ERK2 shows a 60,000 fold rate enhancement over unphosphorylated 
ERK2 (Prowse & Lew, 2001), and previous studies from our lab have shown that 
diphosphorylated mutant LM/GG still maintains ~15-20% activity compared to 2P-ERK2 
(Emrick et al., 2006). A trace amount of 2P-ERK2-LM/GG could have an activity which 
exceeds that of 0P-ERK2-LM/GG, so that the IC50 primarily reflects inhibition of the 
diphosphorylated enzyme. The HX and IC50 data would be consistent, if the binding 
affinity of  AMP-PNP for unphosphorylated LM/GG protein were very low, but the 
affinity of AMP-PNP for diphosphorylated LM/GG were similar to that of wild-type 
ERK2. This is what is observed in p38α MAP kinase, where the Kd for ATP is 360 μM in 
2P-p38α but 13.0 mM in 0P-p38α (Zhang et al. 2005). Taken together the IC50 results 
indicate similar affinity of AMP-PNP for all six ERK2 proteins, but I cannot be sure that 
the affinity measurements reflect unphosphorylated forms of each protein.   
 ITC experiments should provide more accurate measurements of AMP-PNP 
binding affinity, and confirm that my hypothesis regarding LM/GG is correct. These 
experiments are ongoing; to date I have successfully measured Kd = 97 ±33 μM for wild-
type 0P-ERK2, in three experiments performed at 10 °C (Figure 11), which is 
comparable to IC50 estimates. Although the affinity is fairly weak and the C value is low, 
because the goal is to measure equilibrium binding constants without requiring 
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Figure 11: Equilibrium binding of AMP-PNP to 0P-ERK2. 
ITC was used to measure Kd and number of binding sites (N) 
for AMP-PNP binding to 0P-ERK2.  Average values and 
standard deviations measured from n = 3 experiments.  
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characterization of thermodynamic parameters, the experimental conditions are adequate 
(Turnbull & Daranas, 2003). I plan to repeat these experiments for each mutant, in order 
to confirm that LM/GG shows reduced AMP-PNP binding affinity in its 
unphosphorylated form, while ME/GG, ET/GG, and TD/GG show AMP-PNP binding 
comparable to 0P-ERK2. 
 
Does hinge flexibility control enzyme rate? 
 Lastly, I asked whether mutations which increased hinge flexibility and domain 
closure could promote catalytic activity. In other protein kinases, such as MAP kinase 
kinase 1 or protein kinase C, substituting phosphorylatable residues at the activation lip 
with negatively charged amino acids (Glu or Asp) often leads to partial activation by 
mimicking the effect of phosphorylation (e.g., Mansour et al., 1994; Orr & Newton, 
1994).  However, this has been unsuccessful for ERK2 (Zhang et al., 1995), where 
substituting Thr183 and/or Tyr185 to Asp or Glu had minimal effects on enzyme activation 
(Robbins et al., 1993; Zhang et al., 1995). However, I was curious to test whether acidic 
mutations at the activation lip would generate active enzyme when combined with 
mutations that enhanced hinge flexibility. Such a result might be observed if flexibility at 
the hinge and ion pairing interactions at the activation lip are both important for enzyme 
activation.  
 I engineered single or double mutations at Thr183 and Tyr185 to Asp, Glu, or Phe, 
producing the following sequences in place of TEY:  EEY, DEY, TEE, TED, DED, EEE, 
EEF, and DEF. These eight activation lip mutations were then combined with wild-type 
and each of the four hinge mutations, to generate 43 different ERK2 mutants. In addition, 
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each activation lip mutant was generated in its diphosphorylated form by mutagenesis of 
a dual expression plasmid expressing ERK2 and constitutively active MAP kinase kinase 
1 (Khokhlatchev et al., 1997).   Each form was tested for specific activity, measured by 
the initial rate of phosphoryl transfer from [γ-32P]ATP to MBP. Figure 12 shows the 
results of the kinase assays for all ERK2 proteins. The most active enzymes were the four 
single activation lip mutants which were generated from the dual expression plasmid, 
creating monophosphorylated forms of each enzyme; interestingly each showed 
significantly different activity. The combination hinge and activation lip mutations did 
not produce enzymes with exceedingly higher activity over wild-type unphosphorylated 
enzyme, however, both the ME/GG and ET/GG mutants showed specific activities 2-7 
fold higher than unphosphorylated wild-type. Most hinge mutants showed specific 
activity similar to that of wild-type when combined with activation lip mutations (e.g., 
0P-EEE versus ME-EEE).  Only one combinatorial mutant, ME-DED, showed a 30-fold 
increase in specific activity compared to 0P-DED. This example suggests that in at least 
one case, increased flexibility at the hinge combined with negative charge substitutions at 
the lip augments specific activity. However, the effect is rather small, indicating that 
other events are needed for complete activation.    
 
Multiple experiments show reproducible differences upon binding AMP-PNP 
 Multiple analyses were performed in order to accurately judge variability and 
determine the threshold for significance within and across datasets. In order to judge the 
level of variability within a dataset, multiple measurements were performed each at 0 
seconds and 1 minute (Table 2). These measurements provide an assessment of 
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Kinase Assay Results for 1P-ERK2 Mutants  
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Figure 12: Activity measurements for ERK2 mutants. ERK2 mutants were prepared by 
combining various hinge mutations with substitutions of activation lip phosphorylation sites 
with Glu/Asp/Phe.  A. Specific activities were measured for each mutant as described in 
Materials and Methods, and normalized by the specific activity of 0P-ERK2-WT.  Each bar 
represents a different ERK2 mutant, labeled first by the hinge residues which were mutated 
to Gly-Gly, and second by change in activation lip sequence TEY to E, D, or F.  The com-
bined hinge and activation lip mutants show a modest increase in specific activity.  B. Acti-
vation lip mutations (e.g.: EEY) were engineered into plasmids for dual expression of ERK2 
and active mutant MKK1, in order to produce proteins phosphorylated at the activation lip 
(designated “1P”).  The mutants with highest activity were those mono-phosphorylated at 
T183.
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variability in artifactual in-exchange as well as an early time point subject to highest 
error. Table 2 shows the average standard deviation of deuteration at 1 minute (0.12 Da) 
for every peptide from all six ERK2 proteins. This value has remained consistent over 
recent HX-MS experiments that have utilized the current instrumentation (Lee et al. 
2005, Sours et al. 2008), and helped to determine the threshold of significance (0.5 Da) 
for these and previous studies. 
 It is well understood that experimental conditions such as pH, salt concentration, 
and temperature significantly alter the rate of exchange, thus, great care is given to 
minimize these factors. The results discussed in the hinge mutant study involve ERK2 
proteins from six different preparations performed in parallel.  To minimize variation due 
to buffer conditions, proteins are dialyzed into the identical buffer before being frozen in 
aliquots. The pH is also tested with and without AMP-PNP to verify that the presence of 
ligand does not alter the buffer conditions. Such controls improve confidence that the 
average standard deviation of 0.12 Da measures experimental variability and not 
systematic bias. This provides increased confidence in our significance threshold for HX 
changes responsive to AMP-PNP binding. 
 I also examined reproducibility and significance by comparing the results from 
three different HX-MS studies involving ERK2 binding to AMP-PNP, which were 
performed over the past decade by two different experimenters, with different HPLC 
systems and different ERK2 preps. The buffer conditions, concentrations, mass 
spectrometer parameters, and pH were matched as best as time and technology allow, but 
variations in column packing (e.g. theoretical plates, back pressure), amount of ice, 
temperature at quenching, temperature of buffer, etc… were undoubtedly present. I found 
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that the HX time courses were qualitatively similar but quantitatively different (Figure 
13). The peptides where no differences were observed upon AMP-PNP binding showed 
comparable overall exchange with similar time courses between three experiments (Fig 
13C). This showed that regions of ERK2 where HX was unaffected by AMP-PNP 
binding were reproducible between conditions and protein preps.  
When I examined peptides where HX protection by nucleotide was observed, the 
time courses were qualitatively similar, and in all but one case (Fig 13B, Exp 2, C-
terminal hinge) showed a similar level of protection upon AMP-PNP binding (Fig 13A 
and 13B). The Gly-rich loop showed good reproducibility, with approximately 1 Da HX 
protection between all three experiments and similar overall exchange. The C-terminal 
hinge showed similar protection (~0.5 Da) and similar overall exchange in two of three 
experiments. The DFG peptide, which is my metric for domain closure, showed similar 
protection in 2P-ERK2 between all three experiments with slight differences in overall 
exchange, while 0P-ERK2 showed a similar lack of protection and a slight variability in 
overall exchange between two experiments (the third could not be easily interpreted). The 
comparable protection between experiments which we observed between each binding 
study showed that AMP-PNP altered exchange consistently and reproducibly. The 
differences in overall exchange were likely the result of altered back-exchange between 
experimenters and experimental setup. Unfortunately the variability in overall exchange 
and other slight differences due to unavoidable changes made it difficult to directly 
compare fitted rate constants.  
Overall the reproducibility analysis supports the models developed in my thesis, 
namely that AMP-PNP binding conveys protection from exchange in the N-terminal 
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Figure 13: Peptide reproducibility between three different experiments involving ERK2 
binding AMP-PNP. Three experiments were performed over 8 years (2002, 2008, 2010) with 
Experiment 1 performed by a different experimenter with different instrumentation (Lee et al. 
2005) compared to Experiments 2 and 3.  The Experiments are aligned vertically with each 
graph labeled with peptide sequence, 0P- or 2P-ERK2, and the region of the protein. A.  Time 
courses for two peptides showing changes in exchange upon binding AMP-PNP. The time 
courses detail the Gly-rich loop region and the C-terminal hinge. B.  Time courses for the 
conserved DFG peptide comparing 2P-ERK2 for all three experiments and 0P-ERK2 for 
Experiments 1 and 3. A clear pattern of protection in seen in the 2P time courses. C. Three 
peptides where no change in exchange was observed upon binding AMP-PNP.
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domain and the hinge in both 0P- and 2P-ERK2, but conveys increased protection from 
exchange in the C-terminal domain of 2P-ERK2 consistent with changes in solution 
conformation equilibrium which allow 2P-ERK2 to adopt a closed conformation. A 
newly purchased Waters Synapt G2 mass spectrometer with 2D nanoacquity UPLC and 
an HDX module for refrigerated proteolysis and reversed phase chromatography should 
help to further minimize variabilities in buffer temperatures, columns, and back-
exchange, and improve reproducibility between experiments.  
 
DISCUSSION 
 Structural analysis has proven very informative in our understanding of kinase 
function and activation, and in the case of ERK2 it has been beneficial that proteins in 
both the inactive and active states have been crystallized. However, the observed 
structural differences may not completely explain the 60,000-fold rate enhancement upon 
activation by phosphorylation (Prowse & Lew, 2001). There is much evidence for 
interdomain closure as a necessary step in catalysis by protein kinases, such as PKA 
(Knighton et al., 1993; Karlsson et al., 1993; Zheng et al., 1993; Bossemeyer, 1994; Cox 
et al., 1994; Li et al., 2002; Akamine et al., 2003; Heller et al., 2004; Taylor et al., 2004; 
Taylor et al., 2005; Kim et al., 2005; Kim et al., 2006; Vigil et al., 2006; Cheng et al., 
2009).  However, such effects have not been obvious in ERK2, where both the active and 
inactive enzymes are in an “open” conformation.  This may in part reflect distortions in 
the conformation of 2P-ERK2 by crystal packing interactions, where the C-terminus of 
one monomer forms an interface with the active site of another monomer (Canagarajah et 
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al., 1997; Zhang et al., 1995), which makes it difficult to determine whether the open 
conformation represents the solution structure or an artifact of crystallization.  
 HX-MS is able to monitor solution conformational mobility, which is more 
difficult to observe in crystal structures, and this is precisely why I used it in this study. 
To date, HX-MS studies from the Ahn lab have provided the only evidence for 
differences in solution conformation between 0P- and 2P-ERK2 (Lee et al., 2005). 
However, causality is not proven by the studies of Lee et al. (2005), so these experiments 
could be interpreted in more than one way.  On one hand, our laboratory proposes that 
increased HX within the METDL sequence at the hinge upon phosphorylation reflects 
increased backbone flexibility, which in turn allows the kinase to bypass the constraint to 
interdomain interactions, allowing domain closure.  On the other hand, it is conceivable 
that phosphorylation instead leads to interdomain closure, which in turn causes the 
observed enhancement of HX at the hinge.  The results of my study now demonstrate that 
Gly-Gly mutations at the hinge, which should increase backbone flexibility, do appear to 
bypass the constraints to domain closure in 0P-ERK2, as measured by enhanced 
protection from HX at the DFG motif.   
 My HX results together with structural examinations argue that the substitution of 
Gly-Gly for 106Met-Glu107 increases backbone flexibility at the hinge, as expected.  
Previous measurements of HX in peptides comprising the hinge region (101IVQDL105, 
106METDL110, 101IVQDLME110) suggested that within peptide 101IVQDL105, HX occurs 
primarily at amide hydrogens corresponding to Asp104 and Leu105, with estimated kobs ~ 
0.03 min-1 and ~ 0.2 min-1, respectively, and that within peptide 106METDL110, HX occurs 
at Glu107 and Leu110 with estimated kobs ~ 1.7 min-1 and ~ 0.007 min-1, respectively 
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(Resing et al., 1999).  In addition, peptide 101IVQDLME110 showed maximal deuteration 
that was 2 Da higher than in 101IVQDL105, consistent with fast exchange at Met106 and 
Glu107, with estimated kobs >20 min-1 and ~1.7 min-1, respectively (Resing et al., 1999).  
My current results are consistent with previous findings.  In 0P-ERK2, I observed 
maximal deuteration of 3.7 Da in 101IVQDLMETDL110, and maximal deuteration of 1.1 
Da and 1.0 Da in 101IVQDL105 and 106METDL110, respectively (Figure 8, Table 2). In 
mutant protein TD/GG, I observed maximal deuteration of 1.9 Da in peptide 
105LMEGGL110, suggesting that the mutation yielded no further HX over that seen in 
wild-type ERK2.  In contrast, in mutant protein ME/GG, the maximal deuteration was 
~1.7 Da for 106GGTDL110, indicating that the mutation enhanced HX by nearly 1 Da over 
wild-type ERK2 in this region.  Thus, the higher rate of hydrogen exchange in the 
ME/GG mutant is consistent with higher solvent accessibility and/or flexibility at this 
position.   
 The crystal structures show little difference in the hinge region between 0P- and 
2P-ERK2, with respect to hydrogen bonding or distance to surface of amide hydrogens.  
The exception is Glu107, whose amide hydrogen is partially occluded from solvent in 0P-
ERK2, due to a rotation of the Glu107 side chain to form hydrogen bonding interactions 
between the side chain carboxyl group and the amide hydrogen (Figure 14A, Table 4).  
This leads to an increase in distance of the amide hydrogen to the surface of 1 Å (Table 
5).  However, in solution, the side chain of Glu107 should be able to rotate freely, and I 
would not expect there to be a variation in HX protection between 0P- and 2P-ERK2 due 
to this difference between the structures.  Inspection of a surface representation 
comparing 0P-ERK2 to mutants where individual side chains had been removed and 
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2P 0P HMs
Figure 14: Removal of hinge side chains predict increased amide solvent accessibility.  
ERK2 structures showing residues at the hinge region.  ATP is modeled in the active site and 
colored by atom [green (C), red (O), blue (N), orange (P), Mg (sphere)].   A. Top left:  2P-
ERK2, showing the backbone in blue, solvent accessible amides in yellow.  Top middle:  
0P-ERK2, showing the backbone in grey, solvent accessible amides in purple.  Top right:  
0P-ERK2, showing hinge residue side chains removed upon mutation to Gly.  Backbone is 
gold, solvent accessible amides are green.  The mutated residues are highlighted in circles.  
Bottom left, middle and right:  Structures are as indicated in top panels, but compared from 
a different angle.  Residues in and surrounding the hinge (including αD residues 110LYKL113 
and β7 residues 154LLNT157) pack tightly as shown by the surface representation.  2P-ERK2 
was drawn from PDB:2ERK (Canagarajah et al., 1997), 0P-ERK2 was drawn from 
PDB:1ERK (Zhang et al., 1994), and ATP coordinates were adapted from the ERK2 K52R 
structure (PDB:1GOL, Robinson et al., 1996). Images were created using PyMol v.0.99. 
107E->G
106M->G106M->G 106M->G
106M->G
108T->G
109D->G
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Table 4: Hydrogen bonds predicted for the C-terminal hinge peptide of ERK2
0P Hydrogen bonds predicted for hinge residues
Donor 
Atom #
Donor 
Atom
Donor 
Residue
Acceptor 
Atom #
Acceptor 
Atom
Acceptor 
Residue Distance Angle
107 GLU H 107 GLU OE2 2 132.6
108 THR H 155 LEU O 2.36 145.7
108 THR HG1 109 ASP O 2.85 161.01
109 ASP H 108 THR OG1 1.96 125.5
110 LEU H 153 LEU O 1.92 153.5
112 LYS H 109 ASP OD1 1.95 163.16
112 LYS HO 109 ASP OD1 1.95 157.92
113 LEU H 109 ASP O 2.15 176.4
114 LEU H 110 LEU O 1.83 154.8
114 LEU H 110 LEU O 1.77 159.9
155 LEU H 108 THR O 1.91 161.28
157 THR H 107 GLU OE2 3.05 124.9
2P Hydrogen bonds predicted for hinge residues
Donor 
Atom #
Donor 
Atom
Donor 
Residue
Acceptor 
Atom #
Acceptor 
Atom
Acceptor 
Residue Distance Angle
108 THR H 155 LEU O 1.92 173.7
109 ASP H 108 THR OG1 2.01 123.2
110 LEU H 150 PRO O 2.76 124.1
110 LEU H 153 LEU O 2.12 140.9
111 TYR H 109 ASP OD1 2.46 121.1
112 LYS H 109 ASP OD1 1.94 162
113 LEU H 109 ASP O 2.1 148.5
114 LEU H 110 LEU O 1.98 178
155 LEU H 108 THR O 1.74 161.6
Notes
Predicted hydrogen bonds for residues 106METDL110 of 0P- & 2P-ERK2 based on crystal structures.
PDB numbering, atom designation, and residue are listed for H-bond donor & acceptor
H-bond distance and angle were calculated with maximum distance 3.0 Å and angle range 120-180°.
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Table 5: Amide distance to surface measurements for the hinge and DFG regions of 0P- & 2P-ERK2
Hinge Peptide DFG Peptide
Residue Residue # 2P 0P Residue Residue # 2P 0P
Ile 101 5.09 5.44 Lys 162 4.47 3.33
Val 102 5.65 7.89 Ile 163 5.55 2.78
Gln 103 3.63 5.77 Cys 164 4.88 4.82
Asp 104 3.33 4.49 Asp 165 2.47 4.26
Leu 105 1.20 2.42 Phe 166 2.82 4.53
Met 106 1.20 3.74 Gly 167 1.20 4.90
Glu 107 1.20 2.61 Leu 168 1.20 4.07
Thr 108 3.08 2.69
Asp 109 2.80 2.98
Leu 110 4.93 6.30
Notes
Table lists Residue, Residue Number and the estimated Distance to Surface (Å) for 0P- & 2P-ERK2
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residues changed to glycine showed full exposure of the Glu107 amide hydrogen, and 
partial exposure of amide hydrogens corresponding to Thr108 and Asp109 (Figure 14A).  
To the extent that the amide hydrogen for both Glu107 in wild-type ERK2 and Gly107 in 
mutant ME/GG are solvent exposed, I would conclude that the increase in HX by ~1 Da 
observed in the mutant is best explained by enhanced backbone flexibility upon Gly-Gly 
substitutions at positions 106 and 107.  On the other hand, because mutant TD/GG shows 
little change in total in-exchange compared to wild-type ERK2, there is no evidence that 
Gly-Gly substitutions at positions 108 and 109 affect backbone conformational mobility.   
 The focus of my study was the conserved DFG motif within the C-terminal 
domain (162KICDFGL168), where HX protection observed upon AMP-PNP binding 
reflects interdomain closure.  The environment around the KICDFGL sequence is very 
similar between the 0P- and 2P-ERK2 structures (Figure 15), with the exception of 
Asp165, which between the two states is rotated around the Cα-Cβ bond.  The 0P-ERK2 
structure shows a hydrogen bond formed between the carboxyl side chain of Asp165 and 
the backbone amide of Gly165, which is absent in the 2P-ERK2 structure (Table 6).  
Asp165 is known to coordinate with two Mg2+ ions at the active site, which in turn 
coordinate with ATP phosphoryl groups, and the Asp165 in 2P-ERK2 is closer to Mg2+ 
and the phosphoryl groups than in 0P-ERK2.  However, I believe that this rotamer is not 
fixed in 0P-ERK2, given that modeling shows it free to rotate.  This is supported by 
measurements of HX in this region, which in 0P-ERK2 is higher than that seen in 2P-
ERK2, in the absence of AMP-PNP (Figure 9).   
As previously observed by Lee et al. (2005), I found that AMP-PNP binding to 
0P-ERK2 showed less protection from HX within the KICDFGL sequence than 2P-
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AB
Figure 15: Structural models of the DFG region. A. Structural models of peptide 
162KICDFGL168 containing the DFG region in (left, grey) 0P- and (right, blue) 
2P-ERK2, showing hydrogen bonding associated with Asp165.  0P- and 2P-ERK2 
show rotamers  corresponding to Asp165 which different in proximity to ATP and 
Mg2+, but we believe these are probably not fixed in solution.  B. Structures of the 
active site showing the surfaces of the hinge (105METDL110) and DFG 
(162KICDFGL168) regions.  PDB coordinates and colors are as described in Figure 13.
2.99
2.87
2.73
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Table 6: Hydrogen bonds predicted for the DFG peptide residues
0P Hydrogen bonds predicted for DFG peptide residues
Donor 
Atom #
Donor 
Atom
Donor 
Residue
Acceptor 
Atom #
Acceptor 
Atom
Acceptor 
Residue Distance Angle
82 ILE H 163 ILE O 1.94 147.6
154 LEU H 162 LYS O 1.91 157.2
162 LYS H 154 LEU O 2.05 144.8
163 ILE H 80 ASN O 1.85 159.4
164 CYS H 152 ASN O 2.06 160.7
166 PHE H 69 GLU OE2 2.34 166.6
167 GLY H 165 ASP O 2.99 124.7
167 GLY H 165 ASP OD1 2.89 159.4
169 ALA H 166 PHE O 2.5 150.1
2P Hydrogen bonds predicted for DFG peptide residues
Donor 
Atom #
Donor 
Atom
Donor 
Residue
Acceptor 
Atom #
Acceptor 
Atom
Acceptor 
Residue Distance Angle
82 ILE H 163 ILE O 1.86 162.7
154 LEU H 162 LYS O 2 140.6
162 LYS H 154 LEU O 2 145.7
163 ILE H 80 ASN O 1.9 170.2
164 CYS H 152 ASN O 2.16 169.4
166 PHE H 69 GLU OE2 2.19 142.1
167 GLY H 165 ASP O 2.72 126.4
169 ALA H 166 PHE O 2.18 152.4
Notes
Predicted hydrogen bonds for residues 162KICDFGL168 of 0P- & 2P-ERK2 based on crystal structures.
PDB numbering, atom designation, & residue are listed for H-bond donor & acceptor
H-bond distance and angle were calculated with maximum distance 3.0 Å and angle range 120-180°.
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ERK2 (Figure 9).  Because the KICDFGL peptide appeared in all mutant forms of ERK2, 
its extent of HX in 2P-ERK2 and 0P-ERK2 can be used to mark the upper and lower 
range of HX protection upon nucleotide binding.  In mutant ME/GG, the extent of HX in 
this peptide resembles that of 2P-ERK2.  In mutant TD/GG, its extent of HX resembles 
that of 0P-ERK2.  In mutant ET/GG, its extent of HX is intermediate between these 
extremes.  Thus, the mutation ME/GG, which appears to enhance backbone flexibility at 
the hinge to the greatest extent, is the mutation which yields the highest HX protection in 
the DFG region and evidence for interdomain closure.  The HX protection patterns 
observed in wild-type and mutant ERK2 are summarized in Figure 16A.   
I conclude that increased hinge flexibility underlies the mechanism allowing 
domain closure upon ERK2 phosphorylation, consistent with a role for regulated 
conformational mobility in controlling kinase activation.  Figure 16B illustrates this 
model, presenting the hypotheses that hinge flexibility is needed for domain closure, and 
that the increase in conformational mobility in the hinge region upon diphosphorylation 
of ERK2 might be part of the mechanism for bypassing the constraint to closure in 0P-
ERK2.   
 Further experiments are needed to corroborate this mechanism.  A key assumption 
I have made thus far is that AMP-PNP binding is comparable between wild-type and 
mutant ERK2 forms.  Lee et al. (2005) showed comparable Kd for AMP-PNP binding 
between 0P-ERK2 and 2P-ERK2, using isothermal titration calorimetry (ITC).  However, 
my attempts to perform similar measurements on mutant ERK2 have failed, due to 
obstacles in maintaining a constant baseline and problems due to spurious heat gain and 
loss.  An important difference between my experiments and those of Lee et al. (2005) 
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AB
0P 2P ME / ET
Figure 16: A model to explain the importance of hinge flexibility in domain closure. 
A. Surface representations of 0P-ERK2, 2P-ERK2, and mutants ME/GG and ET/GG.  
Shown are peptides that reveal HX protection upon AMP-PNP binding, colored as 
follows: blue - Gly-rich loop; green - αC; cyan - β5/hinge; brown - hinge/αD; red - 
DFG region; orange - activation lip.  The increased protection in the DFG region of the 
mutants ME/GG and ET/GG compared to 0P-ERK2 is similar to that seen in 2P-ERK2, 
indicating that mutations which increase hinge flexibility promote domain closure.  B. 
Cartoon schematics summarizing open and closed states predicted for each ERK2 form 
upon AMP-PNP binding.
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was our use of different ITC instruments, where the older instrument used in previous 
studies had a sample cell which was 7 times larger than the current newer instrument.  
Thus, while the newer instrument is more sensitive, this advantage may be offset by the 
higher signal to noise measurements allowed by the larger cell in prior experiments.  I am 
currently conducting purification strategies to scale up production of ERK2 proteins, in 
order to repeat the experiments at higher concentrations in order to obtain higher signal to 
noise with the new ITC instrument.   
 Finally, I considered the potential effects of hinge flexibility on kinase activity.  
Ideally, the role of hinge flexibility on activation must be tested directly, by asking 
whether changes in flexibility impact kinase activity or activation.  While negative charge 
substitutions at the activation lip sometimes convey higher activity over basal, as in PKC 
(Orr & Newton 1994), the same experiment in ERK2 produced little activation (Zhang et 
al., 1995). Mutations at 183T to Glu/Asp conveyed no increase in activity but led to a 
slight increase in crystallographic B-factors for the activation lip. The mutation of 185Y to 
Glu/Asp also failed to activate, but led to a significant loss of electron density and an 
increase in B-factors to >50 Å2, reflecting significant disorder.  Lastly, the double mutant, 
183T / 185Y to Glu-Xxx-Glu, had the highest degree of disorder, and resulted in no 
increased activity. This was interpreted as the mutations were unable to stabilize the low 
activity 0P form, due to high conformational flexibility of the activation lip, but were also 
unable to promote catalysis because the mutations were unable to form the ion pair 
interactions predicted from homology modeling. While no enzymatic variables were 
measured, other than specific activity, one might predict these mutations would decrease 
Vmax, increase Km for substrate, and have little effect or slightly increase Km for ATP. 
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Nonetheless, I engineered hinge mutations together with mutations which 
incorporated negative charge at the activation lip into the same ERK2 proteins, in order 
to ask whether these mutations could in combination elevate activity.  The results were 
inconclusive, in that specific activities were higher in some combinations, but only by 2-3 
fold, which was insignificant compared to the >1,000 fold increase in rate upon 
diphosphorylation.  If the combined mutants had synergized in elevating activity, it 
would have indicated that hinge flexibility and interdomain closure indeed contribute to 
activation.  An experiment I have yet to perform is to combine hinge mutations with 
single phosphorylation events at the activation lip.  This can be tested by substituting the 
wild type TEY lip sequence with TEF or AEY sequences, combining these with hinge 
mutations, and phosphorylating the combinatorial mutants with active MAP kinase 
kinase 1.  Conceivably, negative charge mutations replacing TEY may not be able to 
stabilize the conformation of the lip enough to enhance catalysis under conditions where 
domain closure is favored by the hinge mutations.  This remains an important goal for the 
future. 
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CHAPTER 4 
 
Future Directions 
 
 My HX-MS experiments on p38α MAP kinase and ERK2 highlight the regulation 
of conformational mobility in protein kinases and changes occurring between inactive, 
unphosphorylated, and active, phosphorylated forms.  My study on p38α MAP kinase 
demonstrated key differences in activation-dependent alterations in HX between p38α 
MAP kinases and ERK2, despite their similarities in overall deuteration.  This suggests 
that, although MAP kinases are closely related with respect to primary sequence and 
tertiary structure, they have distinct mechanisms for dynamical control of enzyme 
function.  My findings on ERK2 indicated that activation-dependent alterations in HX 
provide meaningful contributions to the mechanism of catalytic activation, by controlling 
hinge flexibility and interdomain closure.  A third study, carried out under my 
supervision by undergraduate honors student, Adam Ring, and included as Appendix 2, 
showed that ERK1, a MAP kinase which shares 90% sequence identity with ERK2, also 
shares similarities in overall deuteration, consistent with their similar tertiary structures 
(Ring et al., 2011).  However, the alterations seen in HX at the hinge region in ERK2 
were not observed in ERK1, suggesting that the two enzymes differ with respect to their 
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regulation of hinge mobility and interdomain closure.  Upon AMP-PNP binding, HX-MS 
measurements in the DFG region revealed domain closure in both inactive and active 
forms of ERK1. The results suggest that like p38α MAPK, ERK1 which is even more 
closely related to ERK2 in primary sequence and tertiary structure, utilizes distinct 
mechanisms for controlling enzyme function through interdomain interactions. 
 Future work will require further studies aimed at understanding how regulated 
interdomain closure can be linked to hinge flexibility.  Further studies are needed to 
validate domain closure using alternative approaches.  While the method of monitoring 
protection from HX in the DFG region is so far consistent with my model, I still lack 
direct evidence that the closed conformation is truly achieved.  Some approaches that 
could be used to document the closed conformation in 2P-ERK2 and hinge mutants 
include measurements of domain movements by small angle X-ray scattering (SAXS), 
residual dipolar couplings measured by NMR, and X-ray crystallography.   
Use of small angle X-ray scattering (SAXS) to document interdomain closure has 
been previously done on cAMP-dependent protein kinase (PKA). Olah et al. (1993) 
examined the PKA catalytic subunit in the presence and absence of PKI inhibitor peptide, 
and documented interdomain movement by a decrease in radius of gyration (Rg) of 2 Å 
and 11 Å decrease in dmax in the bound form.  This fit an overall contraction of the 
enzyme with inhibitor bound, upon modeling hinge movement between the two domains 
of the kinase.  We note that in PKA, the hinge residue sequence Gly-Gly is that which 
aligns with 106ME107 in ERK2.  Thus, PKA contains residues that would promote 
flexibility at the pivot point between the two domains, and our ERK2 ME/GG mutant 
121
mimics this sequence.  Thus, it may not be surprising that PKA is able to adopt a closed 
conformation without activation lip phosphorylation.   
Advanced NMR methods can provide distance and angle information from 1H-15N 
and 1H-13C residual dipolar couplings (RDC) (Mittermaier & Kay, 2009; Neudecker et 
al., 2009; Ruschak & Kay, 2010).  RDCs complement distance information from NOE, 
because the couplings have both a distance and angle dependence for the two involved 
nuclei.  Thus, measurement of RDC for two nuclei at a known fixed distance (e.g. 
covalently bonded 1H-15N and 1H-13C) gives information about the angle of the 
internuclear vector relative to the applied magnetic field.  Therefore RDCs can give 
angular information on 1H-15N and 1H-13C bonds in the molecule, and protein solution 
structures can be generated from information about RDC constraints.  Our lab in 
collaboration with Arthur Pardi’s lab are comparing 0P- and 2P- forms of  U-[2H,15N], 
ILV 1H-13C methyl-labeled ERK2 using NMR relaxation experiments (mainly Carr–
Purcell–Meiboom–Gill (CPMG) T2 and/or T1ρ) to monitor Ile, Leu and Val side chain 
motions that correspond to conformational exchange processes with μs-ms timescales.  I 
am not involved in these studies, but conceivably RDC measurements might be used to 
probe changes in interdomain orientation as a future goal. 
A final approach might involve crystallization of the ERK2 hinge mutants in the 
presence or absence of nucleotide, and examination of whether certain mutants are able to 
adopt a closed conformation.  This would provide a readout of the conformational state 
corresponding to the hinge and DFG with atomic resolution, and resolve the ambiguity in 
interpreting the HX protection.  These experiments should be feasible, given that 
crystallization conditions have been found for several wild-type and mutant forms of 
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ERK2, and in my opinion this may be the most feasible of all the possibilities listed 
above for proving that hinge flexibility allows ERK2 to adopt the closed conformation.   
Future studies are also needed to understand how the hinge backbone responds to 
phosphorylation at the activation lip.  The hinge is far from the closest region at which 
conformational differences can be observed upon phosphorylation, therefore, somehow 
information about conformational mobility must be transmitted over long distances in the 
enzyme.  Here, further comparisons of ERK1 and ERK2 may provide an answer.  The 
two enzymes are 90% identical by sequence and greatly overlapping in structure, but 
ERK1 appears to have a more flexible hinge which allows domain closure, even in its 
unphosphorylated, inactive state.  Therefore, the mechanism that constrains domain 
closure in 0P-ERK2 might be found in the sequence and structural variations between 
these enzymes.  One way to approach this problem is to align the sequences and create 
chimeras that swap the 37 amino acids which differ between the enzymes.  For example, 
by substituting residues in ERK2 with those unique to ERK1, we might be able to bypass 
the constraint to closure in 0P-ERK2.  Residues may be swapped one by one, or multiple 
residues may be swapped in various combinations by designing full length cDNAs that 
can be synthesized by contract.  In addition, residues in ERK1 can be substituted for 
those in ERK2, in order to see whether these mutations now confer constraints to closure 
in ERK1.  Effects on hinge flexiblity can be monitored by HX rate measurements, and 
interdomain closure can be monitored by HX protection in the DFG region.  Other assays 
for domain closure, found in studies outlined above, may be used to monitor the closed 
conformation.   
123
  I expect that differences in structure and sequence will account for differences in 
regulated conformational mobility observed between ERK1 and ERK2, measured by 
HXMS.  The regions in ERK1/2 that are most relevant to domain closure are probably 
localized near the hinge, and this will be the region to initially prioritize.  For example, 
comparisons between ERK1 and 2 suggest different packing interactions in the hinge 
region due to the substitution of Leu155 in ERK2 by Ile174 in ERK1.  Leu has helical 
propensity, while Ile favors β-sheets due to steric constraints in the side chain (Steven 
Mayo, personal communication), therefore the residue difference may alter flexibility in a 
manner that depends on the backbone torsion angles.  Even minor changes in packing 
interactions by Leu vs Ile might account for the constrained flexibility in ERK2 not seen 
in ERK1.  Other critical residues may be ERK2-N85 in place of ERK1-R104, which 
disrupts a salt bridge with D104/D123 near the hinge, or ERK1-P35 in place of ERK2-
V16 which may disrupt H-bonds that prevent closure of the ATP loop in ERK2.  By 
systematically testing these and other mutants, and assaying each for interdomain closure 
using methods described in my thesis, we may be able to understand what aspects of 
protein architecture constrain domain closure in ERK2, and ultimately trace the relevant 
pathway in ERK2 that allows activation lip phosphorylation to enhance hinge flexibility 
and releases the constraint to domain closure.    
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APPENDIX A 
 
This appendix lists the primers used to generate the activation lip / hinge double mutants. 
 
P1 T183E 
CATACAGGGTTCTTGGAGGAGTATGTAGCCACGCG 
 
P2 T183E RevComp 
CGCGTGGCTACATACTCCTCCAAGAACCCTGTATG 
 
P3 T183D 
CATACAGGGTTCTTGGACGAGTATGTAGCCACGCG 
 
P4 T183D RevComp 
CGCGTGGCTACATACTCGTCCAAGAACCCTGTATG 
 
P5 T183E/Y185E 
ACAGGGTTCTTGGAGGAGGAGGTAGCCACGCGTTGG 
 
P6 T183E/Y185E RevComp 
CCAACGCGTGGCTACCTCCTCCTCCAAGAACCCTGT 
 
P7 Y185E 
ACAGGGTTCTTGACAGAGGAGGTAGCCACGCGTTGG 
 
P8 Y185E RevComp 
CCAACGCGTGGCTACCTCCTCTGTCAAGAACCCTGT 
 
P9 Y185D 
ACAGGGTTCTTGACAGAGGACGTAGCCACGCGTTGG 
 
P10 Y185D RevComp 
CCAACGCGTGGCTACGTCCTCTGTCAAGAACCCTGT 
 
P11 T183D/Y185D 
ACAGGGTTCTTGGACGAGGACGTAGCCACGCGTTGG 
 
P12 T183D/Y185D RevComp 
CCAACGCGTGGCTACGTCCTCGTCCAAGAACCCTGT 
 
P13 T183E/Y185F 
ACAGGGTTCTTGGAGGAGTTTGTAGCCACGCGTTGG 
 
P14 T183E/Y185F RevComp 
CCAACGCGTGGCTACAAACTCCTCCAAGAACCCTGT 
 
P15 T183D/Y185F 
ACAGGGTTCTTGGACGAGTTTGTAGCCACGCGTTGG 
 
P16 T183D/Y185F RevComp 
CCAACGCGTGGCTACAAACTCGTCCAAGAACCCTGT 
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a b s t r a c t
Hydrogen/deuterium exchange measurements by mass spectrometry (HX-MS) can be used to report
localized conformationalmobilitywithin foldedproteins,where exchangepredominantly occurs through
low energy ﬂuctuations in structure, allowing transient solvent exposure. Changes in conformational
mobilitymay impact protein function, even in caseswhere structural changes are unobservable. Previous
studies of the MAP kinase, ERK2, revealed increases in HX upon activation occurred at the hinge between
conserved N- and C-terminal domains, which could be ascribed to enhanced backbone ﬂexibility. This
implied that kinase activation modulates interdomain closure, and was supported by evidence for two
modes of nucleotide binding that were consistent with closed vs open conformations in active vs inactive
formsofERK2, respectively. Thus, phosphorylationofERK2releases constraints to interdomainclosure, by
modulating hinge ﬂexibility. In this study, we examined ERK1, which shares 90% sequence identity with
ERK2. HX-MS measurements of ERK1 showed similarities with ERK2 in overall deuteration, consistent
with their similar tertiary structures. However, the patterns of HX that were altered upon activation of
ERK1 differed from those in ERK2. In particular, alterations in HX at the hinge region upon activation
of ERK2 did not occur in ERK1, suggesting that the two enzymes differ with respect to their regulation
of hinge mobility and interdomain closure. In agreement, HX-MS measurements of nucleotide binding
suggested revealed domain closure in both inactive and active forms of ERK1. We conclude that although
ERK1 and ERK2 are closely related with respect to primary sequence and tertiary structure, they utilize
distinct mechanisms for controlling enzyme function through interdomain interactions.
© 2010 Elsevier B.V. All rights reserved.
1. Introduction
Extracellular signal-regulated protein kinases, ERK1 and ERK2,
aremitogen-activated protein (MAP) kinaseswhich control diverse
cellular responses, including cell proliferation, differentiation,
transformation, and survival. ERK activation is frequently dysreg-
ulated in human cancers, due to oncogenic mutations in upstream
pathway components, including Ras, Raf, and MAP kinase kinase
(MKK), as well as receptor tyrosine kinases, EGFR, Her2/Neu,
and Met [1,2], all which are attractive targets for drug inter-
vention. Although ERK1 and ERK2 are functionally redundant in
many cell types, each shows a distinct mouse knockout pheno-
type, where deletion of ERK2 leads to embryonic lethality while
deletion of ERK1 yields viable animals with defects in thymo-
cyte maturation and immunodeﬁciency [3,4]. Thus, at least some
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functions of ERK1 and ERK2 are non-redundant. On the other
hand, relatively little is known about how regulatory mecha-
nisms controlling ERK1 and ERK2 differ, which might impact the
development of different strategies for speciﬁcally targeting each
form.
Crystallographic studies of ERK1 and ERK2 show a conserved
tertiary structure shared with all protein kinases, consisting of an
N-terminal ATP binding and C-terminal substrate binding domains
surrounding the catalytic site [5–8]. Both ERK1 and ERK2 are
activated by dual phosphorylation at a conserved pThr-Glu-pTyr
sequence located within the activation lip region, which is cat-
alyzed by the upstream MAP kinase kinases, MKK1 and MKK2.
Structural remodeling events which accompany ERK activation
have been revealed by X-ray structures of inactive, unphospho-
rylated (0P) and active, diphosphorylated (2P) forms of ERK2
[6–8]. Diphosphorylation triggers new phosphate-side chain ion
pair interactions which lead to dramatic conformational changes
within the activation lip, reorganizing the substrate binding site to
enable recognition of the proline-directed phosphorylation motif
(pSer/pThr-Pro), and reorienting active site residues involved in
catalysis.
1387-3806/$ – see front matter © 2010 Elsevier B.V. All rights reserved.
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Hydrogen-exchange mass spectrometry (HX-MS) studies have
shown that protein kinases are regulated not only through changes
in conformation, but also through changes in conformational
mobility. In previous studies of ERK2, comparisons between the
active and inactive states of this kinase revealed increased HX
in the hinge region upon activation, consistent with enhanced
ﬂexibility and conformer interconversions,whichwere not observ-
able byX-ray crystallography [9]. Electron paramagnetic resonance
(EPR) analysis of backbone residues in ERK2 that were individually
coupled to a MTSL nitroxide spin label probe demonstrated that
changes in side chain correlation rates occurred upon phosphory-
lation and activation [10]. Taken together, the results suggested a
model in which the changes in HX could be explained by regulated
protein motions, such as underlying backbone ﬂexibility. Further
measurements of steric protection from HX by the ATP analogue,
AMP-PNP, suggested a function for this control of hinge ﬂexibility.
On one hand, HX within the N-terminal domain was comparable
between 0P-ERK2 and 2P-ERK2, in regions containing the Gly loop,
the conserved Lys-Glu ion pair within 3 and C, the hinge region,
and the catalytic base, all of which are known to form close inter-
actions with nucleotide [11]. On the other hand, 2P-ERK2 showed
10-fold greater protection from HX than 0P-ERK2 within the con-
servedDFGmotif, part of the C-terminal domainwhich formsmetal
coordination interactions with Mg+2–ATP. Thus, AMP–PNP binding
sterically protected both N- and C-terminal domains of 2P-ERK2
from solvent, but mainly protected only the N-terminal domain
of 0P-ERK2. Because the two kinase forms shared similar binding
afﬁnities for AMP-PNP, the results suggested that distinct modes of
nucleotide binding occur in solution. The protection patterns are
consistent with a model in which 2P-ERK2 adopts a closed con-
formation, whereas 0P-ERK2 is somehow constrained to interfere
with interdomain closure. Thus, HX protection by Mg+2–AMP–PNP
binding provides a useful way to monitor domain closure, an event
needed to form a competent catalytic site. These results, together
with the observed changes in hinge ﬂexibility upon activation, led
us topropose that activationof ERK2 releases constraints todomain
closure by increasing backbone ﬂexibility at the hinge [11].
Given their sequence and structural conservation, differentMAP
kinasesmight be expected to show similar regulatorymechanisms.
In agreement, p38MAPkinaseappears toundergoconformational
rearrangements following phosphorylation which parallel those
seen in ERK2. For example, structural comparisons between p38
MAP kinase in its inactive, unphosphorylated form and the related
p38 MAP kinase in its active, diphosphorylated form show large
conformational changes within the activation lip following phos-
phorylation by MKK3/6 [12–14]. Thus, although the activation lip
conformation of 0P-p38MAP kinase differs from that of 0P-ERK2,
the lip conformation of 2P-p38 MAP kinase is similar to that of
2P-ERK2, revealing that diverse activation lip conformers in MAP
kinases converge towards a uniform structure in the active state,
which allows catalytic rate enhancement. In contrast, HX-MS stud-
ies show that p38MAPkinase differs signiﬁcantly fromERK2with
respect to the patterns of regional HX which change in response to
kinase activation [15]. This suggests that the effect of kinase activa-
tion on conformational mobility diverges between related protein
kinases, leading to the hypothesis that different MAP kinases may
have distinct mechanisms for regulating enzyme activity through
their control of internal protein motions.
In this study, we wished to understand whether differences
in patterns of regulated conformational mobility upon activa-
tion might also be observed between enzymes that are even
more closely related. Here, we analyzed ERK1, which shares 90%
sequence identity with ERK2. We found that ERK1 showed signif-
icant differences in how the HX behavior changes in response to
kinase activation within conserved regions of the core structure.
Notably, ERK1 did not display altered HX within hinge residues as
previously observed in ERK2. This suggests that ERK1 might lack
constraints to interdomain closure which are present in the inac-
tive form of ERK2. In order to test this hypothesis, we measured
changes inprotection fromHXuponAMP–PNPbinding inERK1, and
compared these to prior studies of ERK2 [11]. The results showed
signiﬁcant protection from HX within the C-terminal domain of
both 0P-ERK1 and 2P-ERK1, indicating that both inactive and active
forms appear capable of interdomain closure in solution. Thus, the
occurrence and functional effects of regulated protein motions dif-
fer in substantive ways between ERK1 and ERK2.
2. Materials and methods
2.1. Protein puriﬁcation
Active, diphosphorylated (2P) ERK1 was produced from plas-
mid pET-His-ERK1-R4F, containing wild-type human His6-ERK1
expressed in tandem with constitutively active mutant MKK1
(R4F: N3/S218E/S222D) [16]. Inactive, unphosphorylated (0P)
human His6-ERK1 was produced using plasmid NpT7-ERK1 [17].
Each kinase form was expressed in E. coli strain BL21(DE3)-pLysS,
and puriﬁed using Ni-NTA agarose (Qiagen) chromatography,
desalted by gel ﬁltration (PD10, GE Healthcare), and further puri-
ﬁed by MonoQ FPLC. Proteins were dialyzed overnight into 50mM
KPO4 (pH 7.4), 100mM KCl and 5mM dithiothreitol, and stored
in aliquots at −80 ◦C. The 0P-ERK1 protein was found to be
mono-phosphorylated to 0.13mol/mol, and was therefore dephos-
phorylated using  phosphatase (New England Biolabs, 100U/g,
3h, 30 ◦C) before Mono Q separation. The activation lip phospho-
rylation stoichiometries of the ﬁnal kinase preparations showed
0% phosphorylation in 0P-ERK1 at the regulatory Thr and Tyr
residues in the activation lip, and 95% diphosphorylation in 2P-
ERK1. Intact ESI-MS of 0P-ERK1 and 2P-ERK1 showed full length
masses expected of the recombinant ERK1 sequences, in unphos-
phorylated and diphosphorylated forms (Supplementary Fig. S1).
2.2. HX-MS measurements
Datawere collected on aQStar Pulsar QqTOFmass spectrometer
(ABI) interfacedwith anAgilent Cap1100HPLC (0.5mm i.d.×10 cm
column, packed with POROS R1 20 resin), and measurements of
weighted average mass were performed as described [18,19]. Pro-
teins (4g) were incubated in 90% D2O (Sigma) at 10 ◦C, allowing
in-exchange reactions to take place between 8 s and 4h. Reactions
were quenched with 90L 25mM succinic acid, 25mM citric acid
(pH 2.4), and cooled rapidly to 0 ◦C. Proteins were digested by
adding 10L pepsin (4g) and analyzed immediately by LC–MS.
Time-zero measurements were performed by quenching the reac-
tion before adding D2O.
Peptides inpepsindigests of ERK1were identiﬁedbyLC–MS/MS,
analyzing replicate digests on two instruments in order to maxi-
mize the probability that a peptide would be selected for MS/MS.
Aliquots (4g) of proteolyzed ERK1 were analyzed on the QStar
mass spectrometer, with m/z window 400–1600Da, duty cycle
15.5 s, and three MS/MS per cycle. Aliquots (60ng) of ERK1
were analyzed on an LTQ-Orbitrap mass spectrometer interfaced
with an Eksigent 2DLC HPLC (75m i.d.×150mm column, Zor-
bax C18 resin), with m/z window 300–2000Da, duty cycle 4–6 s
(10–14 cycles/min), and ﬁve MS/MS per cycle. MS/MS were con-
verted to .mgf ﬁles and searched against the human ERK1 sequence
using MASCOT (v. 1.9), with no enzyme speciﬁed. Mass tolerances
were 2.5Da (parent) and 1.2Da (fragment) for QStar datasets, and
1.2Da (parent) and 0.6Da (fragment) for LTQ-Orbitrap datasets.
Peptides with MOWSE score greater than 20 were validated by
manual analysis ofMS/MS spectra. LC–MS of ERK1was then carried
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out in water on the QStar, and only peptides with validated MS/MS
that were also observed in the LC–MS run were reported.
HX-MS measurements of protection by Mg+2–AMP–PNP were
carried out as above, with the following modiﬁcations. Prior to
the HX reaction, 8L (5g) of 0P-ERK1 or 2P-ERK1 was incu-
bated on ice for 10min with either 7L of 21mM MgCl2 +2.1mM
AMP–PNP or 7L of 21mM MgCl2. At t=0, exchange was initi-
ated by adding 85L of a D2O/solutemixture to the kinase solution
to reach a ﬁnal buffer composition of 85% (v/v) D2O, 25mM KPO4
(pH 7.4), 50mM KCl, and 0.25mM DTT, 10mM MgCl2, and ±1mM
AMP–PNP. Samples were incubated between 8 s and 110min at
10 ◦C to allow in-exchange, then quenched by acidiﬁcation with
90L 25mMsodiumsuccinate, 25mMsodiumcitrate (pH2.4), and
cooled to 0 ◦C. Proteins were digested by addition of pepsin, and
peptides were analyzed on the QStar mass spectrometer. Time-
zero controls were performed by quenching the sample prior to
addition of the D2O/solute mixture. To avoid systematic variations,
time points and the order of sample analysis ±AMP–PNP were
randomized.
Weightedaveragemassmeasurementswere facilitatedbyusing
in-house HX-Analyzer software [15]. Samples were randomized
to control for systematic variations, and replicate runs were per-
formed at 0 and 60 s in order to quantify the average standard
deviation of weighted average mass (0.05Da) and maximum stan-
dard deviation (0.13Da). Estimates of artifactual in-exchange and
back-exchange were obtained as described [18,19]. Back-exchange
was estimated in twoways. First, back-exchangewas calculated for
each peptide using an empirical formula which assumes 1% back-
exchange per minute after quenching [Eq. (4) in Ref. [18]]. Second,
back-exchange was estimated by desalting and then lyophilizing
peptides generated from pepsin digestion of 2P-ERK1, incubating
with 90% D2O for 90min at 90 ◦C to allow complete in-exchange,
and measuring peptide mass by LC–MS under HX experimental
conditions [18,20]. When counting the number of exchangeable
amides for a given peptide, we included the ﬁrst amide proton and
did not assume rapid back-exchange on the timescale of the exper-
iment. The two methods for estimating back-exchange were in
reasonable agreement,where themeasured values yielded an aver-
age of 28±7% back-exchange for 21 observable peptides, while the
empirical calculation yielded an average of 22±2% back-exchange
for the same peptides. Therefore we applied the second method
involving back-exchange calculations to all peptides.
Fig. 1. Pepsin cleavage map of human ERK1. Shown is the sequence of His6-ERK1, indicating residue numbers and secondary structure as reported by Kinoshita et al. [5].
All peptides indicated were present in LC–MS/MS datasets of ERK1 in water, as well as HX datasets in D2O. Peptides indicated by stippled bars (−8–29, 188–203, and
204–209) were observed only in 0P-ERK1 datasets, and the peptide indicated with horizontal stripes (188–209) was observed only in 2P-ERK1 datasets, reﬂecting differences
in proteolysis in the activation lip. One peptide indicated by a solid bar (173–179) showed increased in-exchange following phosphorylation and activation, and peptides
indicated by dotted ﬁll showed decreased in-exchange following phosphorylation and activation (see time courses in Supplementary Fig. S2).
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After correcting weighted average masses for artifactual
in-exchange and back-exchange, deuteration time courses
were ﬁtted by nonlinear least squares to the equation
Y=N−Ae−k1t −Be−k2t −Ce−k3t, where Y is the number of deuterons
exchanged at time t; A, B, and C are the numbers of backbone
amides exchanging at rates k1, k2, and k3, respectively; and N
is the maximal deuteration over the experimental time period
(N=A+B+C). Subtracting N from the total number of exchangeable
backbone amides yields NE, the number of amides that are non-
exchanging over the experimental time period. Nonlinear least
squares calculations and graphics of time courses were generated
using Sigmaplot v9.0 (SPSS Inc.).
3. Results
3.1. Hydrogen exchange measurements
Hydrogen–deuterium in-exchangemeasurements of ERK1were
obtained by LC–MS as described Section 2. Fifty-ﬁve peptides
were identiﬁed after pepsin proteolysis, ranging in length between
6 and 36 residues (Table S1). These accounted for 98% cover-
age of the primary sequence (370 of 379 residues), and 94%
coverage of exchangeable amides (334 of 356 amides). The pep-
tides are annotated onto the primary sequence of His6-ERK1
in Fig. 1.
Fig. 2. Hydrogen exchange patterns in ERK1. (A and B) Extent of deuteration into (A) 0P-ERK1 and (B) 0P-ERK2 after 4h, normalized by the number of exchangeable amides in
each region. For reach region, the extent of deuteration was measured as the sum of A+B+C (Supplementary Table S2), and mapped as colors corresponding to 0–25% (black),
25–50% (blue), 50–75% (cyan) and >75% (white) of exchangeable amides. Overall, ERK1 and ERK2 showed similar patterns of regional hydrogen exchange, with differences
that could be attributed to variations in sequence or structure. (C and D) Changes in HX induced upon phosphorylation and activation of (C) ERK1 and (D) ERK2. Peptides
that showed increased (red) or decreased (green) HX following activation by phosphorylation were colored against the X-ray structures of 1P-ERK1 (2ZOQ) and 0P-ERK2
(1ERK). Peptides found in only one form of ERK1 or ERK2 (black) precluded comparison between inactive and active kinases. Yellow denotes a peptide in ERK2 which showed
both increased and decreased HX rates upon activation. Of particular interest was the hinge region, which in ERK2 underwent enhanced HX surrounding the pivot point for
interdomain closure, but in ERK1 was unaltered by kinase activation (see Supplementary Fig. S3). Data on ERK2 were from Lee et al. [11].
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Fig. 3. HX time courses for peptides in ERK1 altered upon kinase activation. (A–J) Peptides are labeled by residue numbers as in Table S1, followed by the corresponding
amino acid sequence. HX data on 0P-ERK1 are indicated by closed circles (), and data on 2P-ERK1 are indicated by open circles (©). (I and J) Peptides 120–126 and 125–141
include the hinge region which in ERK1 showed no change upon activation, although HX within the sequence METDL was increased upon activation, in ERK2 [9,11].
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Information about the degree of HX occurring within local-
ized regions of 0P-ERK1 was assessed by measuring the extent of
deuteration into different peptides over the 4h timescale of the
experiment, and mapping these against an X-ray structure deter-
mined for ERK1 [5] (Fig. 2A, Table S2). Slow exchange, leading to
deuteration of <25% of exchangeable amides, was observed within
core regions of the kinase corresponding to helix E and strand 6
within the C-terminal lobe, the latter which contains the catalytic
base within the active site. Slow exchange was also observed in the
loop between helix C and 4 as well as in strand 5, which con-
tain residues that create a hydrophobic core within the N-terminal
lobe. In ERK2, these residues form intramolecular connectivities
with distal residues that in turn prevent autophosphorylation and
autoactivation of the enzyme by constraining ﬂexibility at the
activation lip [21]. Fast exchange, leading to >75% deuteration of
exchangeable amides, was observed within loop regions, includ-
ing part of the activation lip and loops connecting the MAP kinase
insert with C-terminal helices G and H. Deuteration exceeding
Fig. 4. HX time courses for peptides showing protection of ERK1 upon nucleotide binding. (A–H) Peptides from 0P-ERK1 (left panels) and 2P-ERK1 (right panels) show effects
of AMP–PNP binding to ERK1. HX data on apoenzyme were indicated by closed symbols, and data collected with AMP–PNP were indicated by open symbols. Both 0P-ERK1
and 2P-ERK1 showed signiﬁcant protection of HX upon binding AMP–PNP, suggesting interdomain closure in both inactive and active forms.
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50% of exchangeable amides was also observed within N-terminal
loop regions, the P+1 substrate binding loop, and the MAP kinase
insert.
The extent of deuteration in ERK1 revealed many similarities
withpreviousHXmeasurementsof ERK2 [9,11] (Fig. 2AandB). Both
enzymes showed low levels of exchange within the core regions of
the N- and C-terminal domains, including the active site, helices
E and F in the C-terminal domain, and the N-terminal core con-
taining 3–C–4–5. In both enzymes, high levels of exchange
occurred within loops and peripheral secondary structure includ-
ing the N-terminal strands 1LO-2LO and 1–2, intervening
loop regions between 4–5 and F–G, and the MAPK insert.
Interestingly, some dissimilarities in HX behavior were observed
between ERK1 and ERK2. Several prominent regions that under-
went nearly complete in-exchange in ERK2 showed only partial
exchange in ERK1; these included the activation lip and C-terminal
helixL16,which showed <50% exchange in ERK1, but greater than
90% exchange in ERK2. These differences in HX suggested lower
conformational mobility in ERK1 compared to ERK2 within regions
of the molecule linked to catalytic function.
3.2. Regulation of HX by ERK1 activation
Time courses comparing 0P-ERK1 to 2P-ERK1 (Supplementary.
Fig. S2) revealed signiﬁcant changes in hydrogen exchange behav-
ior following activation of ERK1 by dual phosphorylation. Sites
of proteolytic cleavage were nearly identical between the 0P
and 2P forms, with the exception of the activation lip, where
cleavage between residues Glu203 and Tyr204 (numbered as in
Fig. 1) was observed only in the unphosphorylated form of ERK1.
In total, eight peptides exhibited altered in-exchange behavior
between 0P-ERK1 and 2P-ERK1 (Figs. 1 and 3A–H). In 7 of 8 cases,
kinase activation led to decreased HX rates; these included pep-
tide 180–187 (LKICDFGL), containing the conserved DFG motif;
peptide 210–216 (YRAPEIM), containing the P+1 substrate bind-
ing loop; peptides 218–232 (NSKGYTKSIDIWSVG) and 236–254
(AEMLSNRPIFPGKHYLDQL), containing F-G; peptides 255–271
(NHILGILGSPSQEDLNC) and 280–306 (YLQSLPSKTKVAWAKLFPKS-
DSKALDL), containing the L14 MAP kinase insert and H;
and peptide 349–365 (AMELDDLPKERLKIELIF), containing the C-
terminal helix L16. These could either reﬂect structural changes
leading to solvent inaccessibility, or else decreased ﬂexibility and
internal motions, following activation lip phosphorylation. Only
one peptide exhibited increased HX upon activation; this region
corresponded to the 7–8 loop (peptide 173–180, LINTTCDL),
which formspart of a dockingmotif binding site (Fig. 3A), andmight
reﬂect increased backbone ﬂexibility within a binding pocket for
high afﬁnity interactions with substrates, MKKs, and other effec-
tors.
The localized regions which showed HX alterations upon kinase
activation were mapped against the backbone structure of ERK1,
and compared to those previously reported for ERK2 (Figs. 2C
and D). ERK1 and ERK2 showed some similarities in the pat-
terns of HX that were correlated with activity. Both enzymes
showed activation-induced changes in HX within the activation
lip, a region which undergoes signiﬁcant conformational remod-
eling in ERK2, which would also be expected to occur in ERK1.
Decreased HX was observed in both enzymes at the C-terminal
L16helix and surrounding regions,which in ERK2hasbeen shown
to form an interface for dimerization. Similarly, decreased HX was
observed in both enzymes within the P+1 substrate interaction
loop, as well as helices F and G, which comprise the likely inter-
face for extended substrate binding interactions. ERK2 showed
few structural changes within this region that might account for
Fig. 5. Summary of results and conceptual model. (A and B) Peptides protected from HX by Mg+2–AMP–PNP binding are shown in color. (C) Model of results, showing
interdomain interactions leading to domain closure in both 0P- and 2P-ERK1, based on HX protection in the C-terminal domain. (D) Model indicating that in solution,
interdomain interactions leading to domain closure are enhanced in ERK2 by phosphorylation and activation.
150
108 A.Y. Ring et al. / International Journal of Mass Spectrometry 302 (2011) 101–109
the observed changes in HX, suggesting that reduced hydrogen
exchange rates reﬂected decreased conformational mobility fol-
lowing kinase activation. Decreased HX had also been observed in
this region following activation of p38MAP kinase [15], suggest-
ing that decreased ﬂexibility in the substrate binding interface is a
feature common to several MAP kinases.
ERK1 and ERK2 also showed key differences in their pat-
terns of HX regulated by activation. For example, ERK1 showed
no increased HX in the MAP kinase insert, which had previ-
ously been observed in ERK2 and ascribed to disrupted hydrogen
bonding with activation lip residues upon kinase activation [9].
Likewise, ERK1 did not recapitulate the increased HX observed
in the glycine-rich loop upon activation of ERK2, a region impli-
cated in nucleotide binding. Importantly, differences were noted
between the two enzymes in the hinge region localized between
the N- and C-terminal domains, which in cAMP-dependent pro-
tein kinase corresponds to the pivot point for rigid body rotation
and interdomain closure needed for formation of the catalytic
site. In ERK2, this region of the hinge (METDL, Supplementary.
Fig. S3) showed signiﬁcant enhancement of HX upon activa-
tion, which correlated with altered internal motions, allowing
the kinase to switch from an open to closed solution conforma-
tion [9–11]. In contrast, peptide 125–141 (METDLYKLLKSQQLSND),
peptide 125–145 (METDLYKLLKSQQLSNDHICY), and the overlap-
ping peptide 130–145 (YKLLKSQQLSNDHICY) exhibited no change
in HX behavior between active and inactive states in ERK1, from
which we conclude that no change in HX occurs within the
corresponding METDL hinge sequence in ERK1 (Fig. 3I and J,
Supplementary Fig. S3). This suggested that hinge ﬂexibility is
not regulated by activation of ERK1 as it is in ERK2, and that the
two enzymes differ with respect to the regulation of interdomain
closure.
3.3. Domain closure in ERK1 can be monitored by HX-MS
The results above suggested that unlike ERK2, the hinge ﬂex-
ibility of ERK1 might not be controlled by activity state, and
thus might allow interdomain closure in both inactive and active
forms. In order to test this hypothesis, we conducted an HX-MS
experiment which measured the steric protection from HX upon
AMP–PNP binding to ERK1. Prior studies with ERK2 have shown
that AMP–PNP protects N-terminal and hinge regions in the inac-
tive and the active kinase, as expected from the known interactions
between kinases and ATP, and that active ERK2 shows additional
protection of the conserved DFG motif in the C-terminal domain.
Thus, steric protection of the DFG motif reﬂects interdomain clo-
sure between N- and C-terminal lobes in solution. If our hypothesis
were correct, we would expect to see protection of the DFG motif
comparable in both forms of ERK1.
We measured HX time courses in the presence or absence
of 1mM Mg2+–AMP–PNP, comparing inactive vs active ERK1
(Supplementary Fig. S4). Only 20 of the 54 peptides were observed
in these experiments between each of the four conditions, which
nevertheless included most of the ERK1 sequence. Of these, four
peptides showed signiﬁcant reduction in HX rates upon AMP–PNP
binding (Fig. 4A–D). Three of these corresponded to regions which
are known to form contacts with nucleotide within the N-terminal
domain. These included peptide 46–69 (QYIGEGAYGMVSSA), con-
taining the glycine loop which forms hydrogen bond interactions
with  and -phosphate groups of ATP and forms a ﬂexible gate
for nucleotide binding; peptide 60–88 (YDHVRKTRVAIKKISPFEHQ-
TYCQRTLRE), containing conserved Lys and Glu residues in strand
3 and helix C, respectively, which form ion-pair interactions
with ATP  and -phosphate groups; and peptide 115–124 (MRD-
VYIVQDL), containing residues in strand 5 which form hydrogen
bonding interactions with nucleotide (Fig. 4A–C). The fourth pep-
tide, peptide 181–187 (KICDFGL), contains the conserved DFG
motif (Fig. 4D). Here, we observed comparable protection upon
AMP–PNP binding to both inactive and active kinase forms. This
was in contrast to the corresponding DFG region in ERK2, where
previous measurements revealed 10-fold greater nucleotide pro-
tection from HX in the active kinase compared to the inactive form
(Supplementary Fig. S5) [11]. Our measurements of ERK1 indicate
that that nucleotide interacts productively with both the N-and C-
terminal domains in 0P- and 2P-ERK1, and more productively with
the C-terminal domain in 0P-ERK1 than 0P-ERK2. Taken together,
the ﬁndings suggest that both inactive and active forms of ERK1 are
able to adopt interdomain interactions leading to a closed confor-
mation in solution.
4. Discussion
This study reveals novel insight into the manner in which inter-
nalmotions inERK1are regulatedbyenzymeactivation, as revealed
by HX-MS. We demonstrate that ERK1 and ERK2, which are 90%
identical inprimary sequence, showdifferences inHXbehavior that
suggest differences in conformational mobility between closely
related kinases.
InterpretationofHX results canbegreatly aidedby the availabil-
ity of information on atomic structure. Numerous X-ray structures
of ERK2 have been solved in varying forms, including unphos-
phorylated, diphosphorylated, peptide-bound, inhibitor-bound, or
harboringmutationswithin the phosphorylation lip and active site.
In contrast, only one X-ray structure of ERK1 has been published
to date, representing a form which is mono-phosphorylated at its
regulatory Tyr residue (1P-ERK1, Ref. [5]), and whose activity is
approximately 10% of the fully active, diphosphorylated enzyme
[17]. The tertiary structure of ERK1 shows a consensus kinase core
structure containing two insertions unique to MAP kinases (LO,
L14). The backbone conformation is very similar to the struc-
ture of ERK2 [6–8], consistent with the extensive sequence identity
between these enzymes. In its conﬁguration of the activation lip,
the 1P-ERK1 structure appearsmost consistentwithwhatwouldbe
expected for an inactive conformation of the enzyme, resembling
the inactive, unphosphorylated form of ERK2 (0P-ERK2) more than
the active diphosphorylated form (2P-ERK2).
While the overall extent of HX was generally similar between
0P-ERK1 and 0P-ERK2 and consistent with the conserved tertiary
structures, certain dissimilarities were observed. For example, the
extent of HX was lower in ERK1 than ERK2 within the 1LO–2LO
and 1 strands of the N-terminal lobe, and higher in regions sur-
rounding the MAP kinase insertion. Both of these regions showed
signiﬁcant differences in primary sequence as well as structure
(Supplementary Fig. S6 sequence alignment). Likewise, HX was
lower in ERK1 within the 7–8 loop and the C-terminal L16
helix, suggesting lower ﬂexibility. Both regions showed similar
sequences, but higher structural order in ERK1 than ERK2, reﬂected
by closer beta-sheet hydrogenbonding distances in the7–8 loop
of ERK1, as well as an additional helical turn proximal to L16
in ERK1 which was absent in ERK2. Lower HX was also observed
around the activation lip of ERK1, compared to ERK2. Although pri-
mary sequences and conformations were similar between these
regions of ERK1andERK2, residues immediately adjacent to pTyr as
well as within helix C in ERK1 were distorted relative to 0P-ERK2
in a manner suggesting greater similarity to corresponding regions
in 2P-ERK2, which might account for the partial activity of 1P-
ERK1. Thus, for the most part, differences in extent of HX between
ERK1 and ERK2 could be attributed to variations in sequence and/or
structure.
Intriguing differences were observed between ERK1 and ERK2,
when we assessed the effects of phosphorylation and activation
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on conformational mobility. Our previous studies on ERK2 showed
thatenzymeactivation led to signiﬁcant changes inHXwithin local-
ized regions of the protein. These could be attributed to changes
in protein ﬂexibility and internal motions, especially when HX
changes occurred in a manner inconsistent with structural dif-
ferences between 0P-ERK2 and 2P-ERK2. In particular, regions of
ERK2 that showed regulated HX ascribed to changes in ﬂexibil-
ity were those implicated in substrate binding or catalysis, which
could conceivably contribute to enzyme activation. This was fur-
ther examined in the hinge region,where increased ﬂexibility upon
kinase activation correlated with release of constraints to interdo-
main closure. In the case of ERK1, the limitedX-ray informationwas
insufﬁcient to draw dependable conclusions about how well the
changes inHXcouldbeexplainedbychanges in structurevs internal
motions. Nevertheless, to the extent that ERK1 behaves similarly
to ERK2, whose conformational changes were largely restricted to
the activation lip and active site, our HX measurements on ERK1
could conceivably reﬂect effects of activation on protein dynamics.
As in ERK2, the regions showing regulated HX in ERK1 are asso-
ciated with kinase function. Increased HX in ERK1 upon activation
may reﬂect increased mobility of the7–8 loop which is involved
in substrate docking motif recognition. Likewise, reduced mobility
upon activationmight also occur in theDFGmotifwhich is involved
in ATP binding, in the C-terminal helix L16, which is involved in
kinase dimerization, and in the P+1 loop and helicesF–G,which
form the interface for substrate binding and recognition.
Notably, differences were observed between the two enzymes
in thehinge region,which inERK2showed increasedbackboneﬂex-
ibility upon activation, but in ERK1 showed little change between
active and inactive states (Supplementary Fig. S3). Further evi-
dence showing that AMP–PNP interacts productively with N- and
C-terminal domains inboth0P-ERK1and2P-ERK1suggests amodel
in which both the active and inactive states of ERK1 allow inter-
domain closure and formation of a closed active site (Fig. 5). This
behavior differs substantively from ERK2, where constraints to
domain closure consistent with an open solution conformation
were observed in the inactive, unphosphorylated form, and were
released upon activation by diphosphorylation, enabling the for-
mation of a closed solution conformation that would be needed for
catalysis. We conclude that ERK1 and ERK2, while closely related
in sequence and structure, nevertheless differ signiﬁcantly in their
constraints to kinase activation, and themechanismsbywhich they
overcome these barriers through activation-induced regulation of
conformational mobility.
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